US20040116328A1 - Condensed imidazole derivatives - Google Patents
Condensed imidazole derivatives Download PDFInfo
- Publication number
- US20040116328A1 US20040116328A1 US10/457,002 US45700203A US2004116328A1 US 20040116328 A1 US20040116328 A1 US 20040116328A1 US 45700203 A US45700203 A US 45700203A US 2004116328 A1 US2004116328 A1 US 2004116328A1
- Authority
- US
- United States
- Prior art keywords
- group
- formula
- compound
- represented
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 [1*]N1C=CC2=C(C1=O)N(C)C(N(C)C)=N2 Chemical compound [1*]N1C=CC2=C(C1=O)N(C)C(N(C)C)=N2 0.000 description 59
- DTQVDTLACAAQTR-UHFFFAOYSA-N OC(C(F)(F)F)=O Chemical compound OC(C(F)(F)F)=O DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 28
- ZTUIWSJUPJWKLN-UHFFFAOYSA-N CC(C)N1CCCNCCC1 Chemical compound CC(C)N1CCCNCCC1 ZTUIWSJUPJWKLN-UHFFFAOYSA-N 0.000 description 8
- ODIQTOYGORNLPE-UHFFFAOYSA-N CC(C)N1CCN(C)CC1 Chemical compound CC(C)N1CCN(C)CC1 ODIQTOYGORNLPE-UHFFFAOYSA-N 0.000 description 4
- WIYVXOVNPSWAHX-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2 WIYVXOVNPSWAHX-UHFFFAOYSA-N 0.000 description 3
- UQLVOFBTSKFBTE-UHFFFAOYSA-N COC(=O)C(C)CC(C)C.COC(=O)C1(CC(C)C)CC1.COC(=O)CCCC(C)C Chemical compound COC(=O)C(C)CC(C)C.COC(=O)C1(CC(C)C)CC1.COC(=O)CCCC(C)C UQLVOFBTSKFBTE-UHFFFAOYSA-N 0.000 description 3
- LGPWMYSPGVONJL-UHFFFAOYSA-N [H]C1=NN(C)C(=O)C2=C1N=C(N1CCN(C)CC1)N2C.[H]C1=NN(C)C(=O)C2=C1N=C(N1CCN(C)CC1)N2C.[H]C1=NN(C)C(=O)C2=C1N=C(N1CCNCC1)N2C Chemical compound [H]C1=NN(C)C(=O)C2=C1N=C(N1CCN(C)CC1)N2C.[H]C1=NN(C)C(=O)C2=C1N=C(N1CCN(C)CC1)N2C.[H]C1=NN(C)C(=O)C2=C1N=C(N1CCNCC1)N2C LGPWMYSPGVONJL-UHFFFAOYSA-N 0.000 description 3
- WUOQXNWMYLFAHT-UHFFFAOYSA-N [H]N1CCCC(N([H])C(=O)OC(C)(C)C)C1 Chemical compound [H]N1CCCC(N([H])C(=O)OC(C)(C)C)C1 WUOQXNWMYLFAHT-UHFFFAOYSA-N 0.000 description 3
- ACDPHHNDLAXHKH-UHFFFAOYSA-N CC#CCN1C(C2=CC=NC=C2)=NC2=C1C(=O)N(C)N=C2 Chemical compound CC#CCN1C(C2=CC=NC=C2)=NC2=C1C(=O)N(C)N=C2 ACDPHHNDLAXHKH-UHFFFAOYSA-N 0.000 description 2
- TUJKBYYMONTSQH-UHFFFAOYSA-N CC#CCN1C(C2=CC=[N+](CC3=CC=C(OC)C=C3)C=C2)=NC2=C1C(=O)N(C)N=C2.Cl Chemical compound CC#CCN1C(C2=CC=[N+](CC3=CC=C(OC)C=C3)C=C2)=NC2=C1C(=O)N(C)N=C2.Cl TUJKBYYMONTSQH-UHFFFAOYSA-N 0.000 description 2
- RDNKBLSBOLPNSU-UHFFFAOYSA-N CC#CCN1C(Cl)=NC2=C1C(=O)N(C)N=C2 Chemical compound CC#CCN1C(Cl)=NC2=C1C(=O)N(C)N=C2 RDNKBLSBOLPNSU-UHFFFAOYSA-N 0.000 description 2
- YKUAVPQMXBRSGH-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C#N)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C#N)=C1C(=O)OCC YKUAVPQMXBRSGH-UHFFFAOYSA-N 0.000 description 2
- JIBDQCRQUOTIJL-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)C(N)=O)=C1C(=O)OC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)C(N)=O)=C1C(=O)OC JIBDQCRQUOTIJL-UHFFFAOYSA-N 0.000 description 2
- WJFNSKYGHSLTHE-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)O)=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)O)=C1C#N WJFNSKYGHSLTHE-UHFFFAOYSA-N 0.000 description 2
- URCQFLPKUZNCDY-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(C)O)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(C)O)=C1C(=O)OCC URCQFLPKUZNCDY-UHFFFAOYSA-N 0.000 description 2
- LUZQWIDBCBECFY-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(N)=S)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(N)=S)=C1C(=O)OCC LUZQWIDBCBECFY-UHFFFAOYSA-N 0.000 description 2
- YRMZYGVCTKFMOV-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCCOC1CCCCO1)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCCOC1CCCCO1)C(Cl)=N2 YRMZYGVCTKFMOV-UHFFFAOYSA-N 0.000 description 2
- KQASZIGYCGCQDX-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(Cl)=NC(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(Cl)=NC(Cl)=N2 KQASZIGYCGCQDX-UHFFFAOYSA-N 0.000 description 2
- AQMZQKAGTWIRJE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C)=N2.O=C(O)C(F)(F)F AQMZQKAGTWIRJE-UHFFFAOYSA-N 0.000 description 2
- ZHDIRWCCJNNHOU-ZDUSSCGKSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@H]1C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@H]1C(=O)O)=N2.O=C(O)C(F)(F)F ZHDIRWCCJNNHOU-ZDUSSCGKSA-N 0.000 description 2
- VNHMNHCZRLVSOT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(=N)N)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(=N)N)=N2.O=C(O)C(F)(F)F VNHMNHCZRLVSOT-UHFFFAOYSA-N 0.000 description 2
- HXGFRFGXWDGBCK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC)=N2.O=C(O)C(F)(F)F HXGFRFGXWDGBCK-UHFFFAOYSA-N 0.000 description 2
- VSGREWQEVHGECF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC(SC)=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC(SC)=C1)=N2.O=C(O)C(F)(F)F VSGREWQEVHGECF-UHFFFAOYSA-N 0.000 description 2
- RYYBPLBYQMDCQW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC(=O)OCC)=N2.O=C(O)C(F)(F)F RYYBPLBYQMDCQW-UHFFFAOYSA-N 0.000 description 2
- UFLVCUCUWFDEAH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCCOCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCCOCC)=N2.O=C(O)C(F)(F)F UFLVCUCUWFDEAH-UHFFFAOYSA-N 0.000 description 2
- GPQNPNNQNPVAEY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(CC)C(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(CC)C(=O)OCC)=N2.O=C(O)C(F)(F)F GPQNPNNQNPVAEY-UHFFFAOYSA-N 0.000 description 2
- PDLKMODPPCEWPK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(F)C(F)=C(F)C(F)=C1F)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(F)C(F)=C(F)C(F)=C1F)=N2.O=C(O)C(F)(F)F PDLKMODPPCEWPK-UHFFFAOYSA-N 0.000 description 2
- KJYWAGSGBOQZDG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(F)C=CC=C1F)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(F)C=CC=C1F)=N2.O=C(O)C(F)(F)F KJYWAGSGBOQZDG-UHFFFAOYSA-N 0.000 description 2
- GUUOPIAIVMBELM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)O)=N2.O=C(O)C(F)(F)F GUUOPIAIVMBELM-UHFFFAOYSA-N 0.000 description 2
- AZBIJNLEAQNAOK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)OCC)=N2.O=C(O)C(F)(F)F AZBIJNLEAQNAOK-UHFFFAOYSA-N 0.000 description 2
- HALCIKPRHJJAHE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.[H]Cl HALCIKPRHJJAHE-UHFFFAOYSA-N 0.000 description 2
- JUKPMIFLDWFWMX-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1NC(C)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1NC(C)=O)=N2.O=C(O)C(F)(F)F JUKPMIFLDWFWMX-UHFFFAOYSA-N 0.000 description 2
- BOXZPCAHRQVDLD-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=NC=CC=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=NC=CC=N1)=N2.O=C(O)C(F)(F)F BOXZPCAHRQVDLD-UHFFFAOYSA-N 0.000 description 2
- SNBPEQJYGIPAMA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1CCOC1=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1CCOC1=O)=N2.O=C(O)C(F)(F)F SNBPEQJYGIPAMA-UHFFFAOYSA-N 0.000 description 2
- WNCRHURTDBKLDS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCCOC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCCOC)=N2.O=C(O)C(F)(F)F WNCRHURTDBKLDS-UHFFFAOYSA-N 0.000 description 2
- NGOOLYAYEGWOHP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C(=O)O)=N2.O=C(O)C(F)(F)F NGOOLYAYEGWOHP-UHFFFAOYSA-N 0.000 description 2
- SATMJWXFPJMWID-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CC(C)=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CC(C)=N1)=N2.O=C(O)C(F)(F)F SATMJWXFPJMWID-UHFFFAOYSA-N 0.000 description 2
- XQBIKVTXLKCIEW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CC=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CC=N1)=N2.O=C(O)C(F)(F)F XQBIKVTXLKCIEW-UHFFFAOYSA-N 0.000 description 2
- GHKIZMOGWTXWKZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NN=CS1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NN=CS1)=N2.O=C(O)C(F)(F)F GHKIZMOGWTXWKZ-UHFFFAOYSA-N 0.000 description 2
- POSAKWYDXRBFFR-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C(OCC)=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C(OCC)=C1)N=C2.O=C(O)C(F)(F)F POSAKWYDXRBFFR-UHFFFAOYSA-N 0.000 description 2
- USXNKKXKVDCJHR-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(N(C)C)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(N(C)C)=N2.[H]Cl USXNKKXKVDCJHR-UHFFFAOYSA-N 0.000 description 2
- JWTWRMNLDOESHJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(=O)OC)=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(=O)OC)=CC=C1)N=C2.O=C(O)C(F)(F)F JWTWRMNLDOESHJ-UHFFFAOYSA-N 0.000 description 2
- OAIUZVFCINKJGG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)C(OC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)C(OC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F OAIUZVFCINKJGG-UHFFFAOYSA-N 0.000 description 2
- YZWUXPYZOBDCAG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)O)O1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)O)O1)N=C2.O=C(O)C(F)(F)F YZWUXPYZOBDCAG-UHFFFAOYSA-N 0.000 description 2
- FGGCMECJFXKANE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(N(C)CC(=O)OCC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(N(C)CC(=O)OCC)=N2.[H]Cl FGGCMECJFXKANE-UHFFFAOYSA-N 0.000 description 2
- SWGGHFKTKLAMSK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OCC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OCC)=N2.[H]Cl SWGGHFKTKLAMSK-UHFFFAOYSA-N 0.000 description 2
- UZEOBXRPMDENQD-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C=NN(C)C2=O.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C=NN(C)C2=O.O=C(O)C(F)(F)F UZEOBXRPMDENQD-UHFFFAOYSA-N 0.000 description 2
- ZOUUXALGMWJKRO-UHFFFAOYSA-N CC#CCN1C=NC2=C1C(=O)N(C)C(=O)N2COC(=O)C(C)(C)C Chemical compound CC#CCN1C=NC2=C1C(=O)N(C)C(=O)N2COC(=O)C(C)(C)C ZOUUXALGMWJKRO-UHFFFAOYSA-N 0.000 description 2
- PZCHQKKGJBFMFI-RQWLHMMPSA-N CC(C)N1CCCC(N)C1.CC(C)N1CCC[C@@H](N)C1.CC(C)N1CCC[C@H](C)C1 Chemical compound CC(C)N1CCCC(N)C1.CC(C)N1CCC[C@@H](N)C1.CC(C)N1CCC[C@H](C)C1 PZCHQKKGJBFMFI-RQWLHMMPSA-N 0.000 description 2
- ODYBNXDUGIYUHY-UHFFFAOYSA-N CC1=NC2=C(C(C)=N1)N(C)C(C)=N2 Chemical compound CC1=NC2=C(C(C)=N1)N(C)C(C)=N2 ODYBNXDUGIYUHY-UHFFFAOYSA-N 0.000 description 2
- HEYWWSWHJPTEKN-UHFFFAOYSA-N CCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F HEYWWSWHJPTEKN-UHFFFAOYSA-N 0.000 description 2
- FMCKMIJRWUAVJL-UHFFFAOYSA-N CN(C)C1=NN(C)C(=O)C2=C1NC(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 Chemical compound CN(C)C1=NN(C)C(=O)C2=C1NC(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 FMCKMIJRWUAVJL-UHFFFAOYSA-N 0.000 description 2
- BGTXNPUMKNACIX-UHFFFAOYSA-N CN1C(=O)C2=C(N=C(N3CCN(C(=O)OC(C)(C)C)CC3)N2C2=C(Cl)C=CC=C2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CN1C(=O)C2=C(N=C(N3CCN(C(=O)OC(C)(C)C)CC3)N2C2=C(Cl)C=CC=C2)N(COC(=O)C(C)(C)C)C1=O BGTXNPUMKNACIX-UHFFFAOYSA-N 0.000 description 2
- JIBTZNUBCPRRNP-UHFFFAOYSA-N CN1N=CC2=C(NC(C3CCN(C(=O)OC(C)(C)C)CC3)=N2)C1=O Chemical compound CN1N=CC2=C(NC(C3CCN(C(=O)OC(C)(C)C)CC3)=N2)C1=O JIBTZNUBCPRRNP-UHFFFAOYSA-N 0.000 description 2
- GRLWCHGMPBDUKL-UHFFFAOYSA-N N#CCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound N#CCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F GRLWCHGMPBDUKL-UHFFFAOYSA-N 0.000 description 2
- WMSQDGWQPKIRTA-UHFFFAOYSA-N O=C(O)C(F)(F)F.[H]N1CCN(C2=NC3=C(C(=O)N(C)N=C3)N2CC#CC)CC1 Chemical compound O=C(O)C(F)(F)F.[H]N1CCN(C2=NC3=C(C(=O)N(C)N=C3)N2CC#CC)CC1 WMSQDGWQPKIRTA-UHFFFAOYSA-N 0.000 description 2
- KCKAVPQAAIGTMY-UHFFFAOYSA-N C#CC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound C#CC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F KCKAVPQAAIGTMY-UHFFFAOYSA-N 0.000 description 1
- LSYRJTSUBBHDNG-UHFFFAOYSA-N C#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound C#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F LSYRJTSUBBHDNG-UHFFFAOYSA-N 0.000 description 1
- DEOCQNSUULBFDJ-UHFFFAOYSA-N C#CCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound C#CCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F DEOCQNSUULBFDJ-UHFFFAOYSA-N 0.000 description 1
- IXEPXVWHJUXSTR-UHFFFAOYSA-N C#CCN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound C#CCN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F IXEPXVWHJUXSTR-UHFFFAOYSA-N 0.000 description 1
- GLUZFMNYYXDFLF-UHFFFAOYSA-N C#CCN1N=NC2=C(C1=O)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound C#CCN1N=NC2=C(C1=O)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F GLUZFMNYYXDFLF-UHFFFAOYSA-N 0.000 description 1
- DGZWCXNYNMCLIS-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=N1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=N1)N=C2.O=C(O)C(F)(F)F DGZWCXNYNMCLIS-UHFFFAOYSA-N 0.000 description 1
- YKPRWBNHRTUKJY-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CN=C1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CN=C1)N=C2.O=C(O)C(F)(F)F YKPRWBNHRTUKJY-UHFFFAOYSA-N 0.000 description 1
- NADTYRIBJNMXIN-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=NC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=NC=C1)N=C2.O=C(O)C(F)(F)F NADTYRIBJNMXIN-UHFFFAOYSA-N 0.000 description 1
- LVFDELFWUXDSRR-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=NC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=NC=C1)N=C2.O=C(O)C(F)(F)F LVFDELFWUXDSRR-UHFFFAOYSA-N 0.000 description 1
- OYBJDSSTJWJMRR-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CN=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CN=CC=C1)N=C2.O=C(O)C(F)(F)F OYBJDSSTJWJMRR-UHFFFAOYSA-N 0.000 description 1
- ZSFMAKKGDWUTJU-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC=C(C(=O)OC)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC=C(C(=O)OC)C=C1)N=C2.O=C(O)C(F)(F)F ZSFMAKKGDWUTJU-UHFFFAOYSA-N 0.000 description 1
- SUAAYOHYWZLDSN-UHFFFAOYSA-N C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound C.CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC=CC=C1)N=C2.O=C(O)C(F)(F)F SUAAYOHYWZLDSN-UHFFFAOYSA-N 0.000 description 1
- CXDRTHZBQKPUBG-UHFFFAOYSA-N C.O=C(O)C(F)(F)F.[H]N([H])C1=C(C(=O)CN2N=CC3=C(C2=O)N(CC#CC)C(N2CCNCC2)=N3)C=CC=C1 Chemical compound C.O=C(O)C(F)(F)F.[H]N([H])C1=C(C(=O)CN2N=CC3=C(C2=O)N(CC#CC)C(N2CCNCC2)=N3)C=CC=C1 CXDRTHZBQKPUBG-UHFFFAOYSA-N 0.000 description 1
- NNKOFRKZUCROLF-UHFFFAOYSA-N C=CCN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2CC#CC Chemical compound C=CCN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2CC#CC NNKOFRKZUCROLF-UHFFFAOYSA-N 0.000 description 1
- VJGLGJDSQYPPGN-UHFFFAOYSA-N C=CCN1C(=O)C2=C(N=C1OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl Chemical compound C=CCN1C(=O)C2=C(N=C1OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl VJGLGJDSQYPPGN-UHFFFAOYSA-N 0.000 description 1
- LCVKDNHRXVIXJP-UHFFFAOYSA-N C=CCN1C(=O)C2=C(N=C1SCC(=O)OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl Chemical compound C=CCN1C(=O)C2=C(N=C1SCC(=O)OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl LCVKDNHRXVIXJP-UHFFFAOYSA-N 0.000 description 1
- TYJFNXPGACBFCH-UHFFFAOYSA-N C=CCN1C(=O)N(C)C2=C1C=CN=C2Cl.C=CCN1C(=O)NC2=C1C=CN=C2Cl.C=CCNC1=C(N)C(Cl)=NC=C1.C=CCNC1=C([N+](=O)[O-])C=NC=C1.CC.CCOC1=C([N+](=O)[O-])C=NC=C1.CN1C(=O)NC2=C1C(Cl)=NC=C2.CN1C(Cl)=NC2=C1C(Cl)=NC=C2.CN1C(N2CCNCC2)=NC2=C1C(=O)NC=C2.CN1CCN(C2=NC3=C(C(Cl)=NC=C3)N2C)CC1.CN1CCNCC1 Chemical compound C=CCN1C(=O)N(C)C2=C1C=CN=C2Cl.C=CCN1C(=O)NC2=C1C=CN=C2Cl.C=CCNC1=C(N)C(Cl)=NC=C1.C=CCNC1=C([N+](=O)[O-])C=NC=C1.CC.CCOC1=C([N+](=O)[O-])C=NC=C1.CN1C(=O)NC2=C1C(Cl)=NC=C2.CN1C(Cl)=NC2=C1C(Cl)=NC=C2.CN1C(N2CCNCC2)=NC2=C1C(=O)NC=C2.CN1CCN(C2=NC3=C(C(Cl)=NC=C3)N2C)CC1.CN1CCNCC1 TYJFNXPGACBFCH-UHFFFAOYSA-N 0.000 description 1
- PTBCPIFRRQSXQL-UHFFFAOYSA-N C=CCN1C(=O)N(CC2=CC=CC=C2)C2=C(Cl)N=CC=C21 Chemical compound C=CCN1C(=O)N(CC2=CC=CC=C2)C2=C(Cl)N=CC=C21 PTBCPIFRRQSXQL-UHFFFAOYSA-N 0.000 description 1
- SGXJIRANAFHZED-UHFFFAOYSA-N C=CCNC1=CC=NC(Cl)=C1N Chemical compound C=CCNC1=CC=NC(Cl)=C1N SGXJIRANAFHZED-UHFFFAOYSA-N 0.000 description 1
- OWOTYICBSOOOGZ-UHFFFAOYSA-N C=CCNC1=CC=NC=C1[N+](=O)[O-] Chemical compound C=CCNC1=CC=NC=C1[N+](=O)[O-] OWOTYICBSOOOGZ-UHFFFAOYSA-N 0.000 description 1
- VWGMRSMHBXMELD-UHFFFAOYSA-N C=CCSC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound C=CCSC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F VWGMRSMHBXMELD-UHFFFAOYSA-N 0.000 description 1
- KAHIVZSPHHVLGY-UHFFFAOYSA-N CC#CCN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2CC#CC Chemical compound CC#CCN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2CC#CC KAHIVZSPHHVLGY-UHFFFAOYSA-N 0.000 description 1
- SJDWSIZGGIEIMB-UHFFFAOYSA-N CC#CCN1C(=O)C2=C(N=C1OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl Chemical compound CC#CCN1C(=O)C2=C(N=C1OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl SJDWSIZGGIEIMB-UHFFFAOYSA-N 0.000 description 1
- YGARATVRKHSVJI-UHFFFAOYSA-N CC#CCN1C(=O)C2=C(N=C1SCC(=O)OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl Chemical compound CC#CCN1C(=O)C2=C(N=C1SCC(=O)OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl YGARATVRKHSVJI-UHFFFAOYSA-N 0.000 description 1
- OIKJTRFVCZPRQR-UHFFFAOYSA-N CC#CCN1C(Br)=NC(C#N)=C1C#N Chemical compound CC#CCN1C(Br)=NC(C#N)=C1C#N OIKJTRFVCZPRQR-UHFFFAOYSA-N 0.000 description 1
- HKFKJOKMFLBULX-UHFFFAOYSA-N CC#CCN1C(Br)=NC(C#N)=C1C(=O)OCC Chemical compound CC#CCN1C(Br)=NC(C#N)=C1C(=O)OCC HKFKJOKMFLBULX-UHFFFAOYSA-N 0.000 description 1
- KSSINHDEAXFKGB-UHFFFAOYSA-N CC#CCN1C(Br)=NC(C(=O)OCC)=C1C#N Chemical compound CC#CCN1C(Br)=NC(C(=O)OCC)=C1C#N KSSINHDEAXFKGB-UHFFFAOYSA-N 0.000 description 1
- IAJJGGLWDLAHMW-UHFFFAOYSA-N CC#CCN1C(C2=CCN(CC3=CC=C(OC)C=C3)CC2)=NC2=C1C(=O)N(C)N=C2 Chemical compound CC#CCN1C(C2=CCN(CC3=CC=C(OC)C=C3)CC2)=NC2=C1C(=O)N(C)N=C2 IAJJGGLWDLAHMW-UHFFFAOYSA-N 0.000 description 1
- NXHFZUAKNYFXHB-UHFFFAOYSA-N CC#CCN1C(C2=CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(C2=CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F NXHFZUAKNYFXHB-UHFFFAOYSA-N 0.000 description 1
- LFSSOFWLVZSCRS-UHFFFAOYSA-N CC#CCN1C(C2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2 Chemical compound CC#CCN1C(C2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2 LFSSOFWLVZSCRS-UHFFFAOYSA-N 0.000 description 1
- FJIQIESRIFCPLG-UHFFFAOYSA-N CC#CCN1C(C2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(C2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F FJIQIESRIFCPLG-UHFFFAOYSA-N 0.000 description 1
- JKCRLJMWFIRHLF-UHFFFAOYSA-N CC#CCN1C(Cl)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(=O)N2COC(=O)C(C)(C)C Chemical compound CC#CCN1C(Cl)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(=O)N2COC(=O)C(C)(C)C JKCRLJMWFIRHLF-UHFFFAOYSA-N 0.000 description 1
- SJEXZCRZWVWXPY-UHFFFAOYSA-N CC#CCN1C(Cl)=NC2=C1C(=O)NC(=O)N2C Chemical compound CC#CCN1C(Cl)=NC2=C1C(=O)NC(=O)N2C SJEXZCRZWVWXPY-UHFFFAOYSA-N 0.000 description 1
- GEJWNLQRMVMTIX-UHFFFAOYSA-N CC#CCN1C(Cl)=NC2=C1C(Cl)=NC(Cl)=N2 Chemical compound CC#CCN1C(Cl)=NC2=C1C(Cl)=NC(Cl)=N2 GEJWNLQRMVMTIX-UHFFFAOYSA-N 0.000 description 1
- BMAPQWNOXDZABF-UHFFFAOYSA-N CC#CCN1C(Cl)=NC2=C1C=NN(C)C2=O Chemical compound CC#CCN1C(Cl)=NC2=C1C=NN(C)C2=O BMAPQWNOXDZABF-UHFFFAOYSA-N 0.000 description 1
- YMWRFWNBXYLKOL-UHFFFAOYSA-N CC#CCN1C(Cl)=NC2=CC=NC(Cl)=C21 Chemical compound CC#CCN1C(Cl)=NC2=CC=NC(Cl)=C21 YMWRFWNBXYLKOL-UHFFFAOYSA-N 0.000 description 1
- PURJXZLXVDDDON-UHFFFAOYSA-N CC#CCN1C(N2CCC(N)C2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCC(N)C2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.[H]Cl PURJXZLXVDDDON-UHFFFAOYSA-N 0.000 description 1
- BIFGXZVJELBIIE-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N(C)C(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(C)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(N(C)C(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(C)C(Cl)=N2 BIFGXZVJELBIIE-UHFFFAOYSA-N 0.000 description 1
- IPLFRBMCNZKIDY-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N(C)C(=O)OC(C)(C)C)C2)=NC2=C1C(Cl)=NC(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(N(C)C(=O)OC(C)(C)C)C2)=NC2=C1C(Cl)=NC(Cl)=N2 IPLFRBMCNZKIDY-UHFFFAOYSA-N 0.000 description 1
- ZCXIADKWZRUYLK-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(N(CC)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(N(CC)CC)=N2.O=C(O)C(F)(F)F ZCXIADKWZRUYLK-UHFFFAOYSA-N 0.000 description 1
- OBRNPXHEBXNVLM-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(N1CCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(N1CCCC1)=N2.O=C(O)C(F)(F)F OBRNPXHEBXNVLM-UHFFFAOYSA-N 0.000 description 1
- ZHQHVHBYAUSDNF-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(OC)=N2.O=C(O)C(F)(F)F ZHQHVHBYAUSDNF-UHFFFAOYSA-N 0.000 description 1
- MCDVONWBGWMDDM-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F MCDVONWBGWMDDM-UHFFFAOYSA-N 0.000 description 1
- KJZHUSWLRQEQNL-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(SC(C)(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(C)C(SC(C)(C)C)=N2.O=C(O)C(F)(F)F KJZHUSWLRQEQNL-UHFFFAOYSA-N 0.000 description 1
- LNSLGSKJYPHTJJ-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(OC)=N2.[H]Cl LNSLGSKJYPHTJJ-UHFFFAOYSA-N 0.000 description 1
- XHWOZPOPNIJJNW-UHFFFAOYSA-N CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCCC(N)C2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OC)=N2.[H]Cl XHWOZPOPNIJJNW-UHFFFAOYSA-N 0.000 description 1
- NTQIOJWZJVAXOB-UHFFFAOYSA-N CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(C)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(C)C(Cl)=N2 NTQIOJWZJVAXOB-UHFFFAOYSA-N 0.000 description 1
- IHLOTMVZLUVSHD-UHFFFAOYSA-N CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(Cl)=N2 IHLOTMVZLUVSHD-UHFFFAOYSA-N 0.000 description 1
- LWXXIJLTAVYPOD-UHFFFAOYSA-N CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(Cl)=N2 LWXXIJLTAVYPOD-UHFFFAOYSA-N 0.000 description 1
- CDCNRSYOAHQINO-UHFFFAOYSA-N CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)NC(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(=O)NC(Cl)=N2 CDCNRSYOAHQINO-UHFFFAOYSA-N 0.000 description 1
- DFROGOVLKYFOGZ-UHFFFAOYSA-N CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(Cl)=NC(Cl)=N2 Chemical compound CC#CCN1C(N2CCCC(NC(=O)OC(C)(C)C)C2)=NC2=C1C(Cl)=NC(Cl)=N2 DFROGOVLKYFOGZ-UHFFFAOYSA-N 0.000 description 1
- IJLLXZZKQNBULW-UHFFFAOYSA-N CC#CCN1C(N2CCCC(NC)C2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCCC(NC)C2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2.[H]Cl IJLLXZZKQNBULW-UHFFFAOYSA-N 0.000 description 1
- WNVHLSVVUGBDNS-BQYQJAHWSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/C(=O)N=[N+]=[N-])=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/C(=O)N=[N+]=[N-])=C1C#N WNVHLSVVUGBDNS-BQYQJAHWSA-N 0.000 description 1
- BIEUWRRUZGWNDA-BQYQJAHWSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/C(=O)O)=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/C(=O)O)=C1C#N BIEUWRRUZGWNDA-BQYQJAHWSA-N 0.000 description 1
- KRJWCXUMGFQFJE-MDZDMXLPSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/C(=O)OCC)=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/C(=O)OCC)=C1C#N KRJWCXUMGFQFJE-MDZDMXLPSA-N 0.000 description 1
- XNEFSIQZPQBKOD-ZHACJKMWSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/NC(=O)OC(C)(C)C)=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/NC(=O)OC(C)(C)C)=C1C#N XNEFSIQZPQBKOD-ZHACJKMWSA-N 0.000 description 1
- YBFGSUBTYFTOAX-ZHACJKMWSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/NC(=O)OC(C)(C)C)=C1C(N)=O Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(/C=C/NC(=O)OC(C)(C)C)=C1C(N)=O YBFGSUBTYFTOAX-ZHACJKMWSA-N 0.000 description 1
- MWMFSWHXCLYDKX-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=N)SC)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=N)SC)=C1C(=O)OCC MWMFSWHXCLYDKX-UHFFFAOYSA-N 0.000 description 1
- MFMXUWGMLQCLJX-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)C2=CC=CC=C2)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)C2=CC=CC=C2)=C1C(=O)OCC MFMXUWGMLQCLJX-UHFFFAOYSA-N 0.000 description 1
- MRXLPCMJTVKIDR-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)OCC)=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)OCC)=C1C#N MRXLPCMJTVKIDR-UHFFFAOYSA-N 0.000 description 1
- FTWAAONEHXCFSK-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)SC)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(=O)SC)=C1C(=O)OCC FTWAAONEHXCFSK-UHFFFAOYSA-N 0.000 description 1
- LENLVMABVDGDSG-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(C)=O)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(C)=O)=C1C(=O)OCC LENLVMABVDGDSG-UHFFFAOYSA-N 0.000 description 1
- MWZONKBOYKVTHA-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C#N)=C1C(=O)OC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C#N)=C1C(=O)OC MWZONKBOYKVTHA-UHFFFAOYSA-N 0.000 description 1
- LDMRSYRXYKKARH-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C(F)(F)F)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C(F)(F)F)=C1C(=O)OCC LDMRSYRXYKKARH-UHFFFAOYSA-N 0.000 description 1
- FRTUZXLLAVXVRI-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C(N)=O)=C1C(=O)OC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C(N)=O)=C1C(=O)OC FRTUZXLLAVXVRI-UHFFFAOYSA-N 0.000 description 1
- PJMRANOSAXIKJZ-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C2=CC=CC=C2)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(C(O)C2=CC=CC=C2)=C1C(=O)OCC PJMRANOSAXIKJZ-UHFFFAOYSA-N 0.000 description 1
- ZWEMEPJPSNHVRA-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C#N Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C#N ZWEMEPJPSNHVRA-UHFFFAOYSA-N 0.000 description 1
- IVUJUEAKTIQKCZ-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C(=O)OCC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C(=O)OCC IVUJUEAKTIQKCZ-UHFFFAOYSA-N 0.000 description 1
- KZCCKFAPSKZGSZ-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C(=O)SC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C(=O)SC KZCCKFAPSKZGSZ-UHFFFAOYSA-N 0.000 description 1
- NMDUDRDTALDXCO-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C(N)=S Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO)=C1C(N)=S NMDUDRDTALDXCO-UHFFFAOYSA-N 0.000 description 1
- OILWVKQGDCBTNM-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO[Si](C2=CC=CC=C2)(C2=CC=CC=C2)C(C)(C)C)=C1C(=N)SC Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO[Si](C2=CC=CC=C2)(C2=CC=CC=C2)C(C)(C)C)=C1C(=N)SC OILWVKQGDCBTNM-UHFFFAOYSA-N 0.000 description 1
- WBUZPUZMJGOXMG-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO[Si](C2=CC=CC=C2)(C2=CC=CC=C2)C(C)(C)C)=C1C(N)=S Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC(CO[Si](C2=CC=CC=C2)(C2=CC=CC=C2)C(C)(C)C)=C1C(N)=S WBUZPUZMJGOXMG-UHFFFAOYSA-N 0.000 description 1
- MDWHIBXKXGCKML-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C(=O)OCC1=CC=CC=C1)C(C(=O)OC)=C2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C(=O)OCC1=CC=CC=C1)C(C(=O)OC)=C2 MDWHIBXKXGCKML-UHFFFAOYSA-N 0.000 description 1
- DXESPWLBISCQPL-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(=O)N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(=O)N2 DXESPWLBISCQPL-UHFFFAOYSA-N 0.000 description 1
- ADYIYJATSSKFKN-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(C(N)=O)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(C(N)=O)=N2 ADYIYJATSSKFKN-UHFFFAOYSA-N 0.000 description 1
- DRJQXHGMGWUQBT-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(Cl)=N2 DRJQXHGMGWUQBT-UHFFFAOYSA-N 0.000 description 1
- HEBSZPRRWBUABV-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(N)=O)=N2 HEBSZPRRWBUABV-UHFFFAOYSA-N 0.000 description 1
- MKQDKJPSJLKXKW-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2C(N)=O Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2C(N)=O MKQDKJPSJLKXKW-UHFFFAOYSA-N 0.000 description 1
- MCOFTCLFEJLYAS-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC(=O)C1=C([N+](=O)[O-])C=CC=C1)N=C2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC(=O)C1=C([N+](=O)[O-])C=CC=C1)N=C2 MCOFTCLFEJLYAS-UHFFFAOYSA-N 0.000 description 1
- CADUDCPRQQWNSI-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(Cl)=N2 CADUDCPRQQWNSI-UHFFFAOYSA-N 0.000 description 1
- WJNMQASULXZNJA-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(N(C)C)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C(N(C)C)=N2 WJNMQASULXZNJA-UHFFFAOYSA-N 0.000 description 1
- QCLWNOVVTREOAB-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)C(Cl)=N2 QCLWNOVVTREOAB-UHFFFAOYSA-N 0.000 description 1
- IYMJDEBSFXOPFX-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(=O)N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(=O)N2 IYMJDEBSFXOPFX-UHFFFAOYSA-N 0.000 description 1
- YICLJVMFKJUXFR-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(Cl)=N2 YICLJVMFKJUXFR-UHFFFAOYSA-N 0.000 description 1
- UXICPTZWRYBEDH-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCOC)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(CCOC)C(Cl)=N2 UXICPTZWRYBEDH-UHFFFAOYSA-N 0.000 description 1
- ANOXWVYCKAJLFR-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(COCC1=CC=CC=C1)N=C2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(COCC1=CC=CC=C1)N=C2 ANOXWVYCKAJLFR-UHFFFAOYSA-N 0.000 description 1
- ZCDYJCYFQAJHPK-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N1CCCOC1=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N1CCCOC1=N2 ZCDYJCYFQAJHPK-UHFFFAOYSA-N 0.000 description 1
- IVQRBRILXJUXCS-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC(C(OC)(OC)OC)=C2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC(C(OC)(OC)OC)=C2 IVQRBRILXJUXCS-UHFFFAOYSA-N 0.000 description 1
- VVWARAROKUOPQX-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC(Cl)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC(Cl)=N2.[H]Cl VVWARAROKUOPQX-UHFFFAOYSA-N 0.000 description 1
- UGUMKZDZJGZAFS-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC=C2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC=C2 UGUMKZDZJGZAFS-UHFFFAOYSA-N 0.000 description 1
- UAKLZWVXVMRJQS-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC=N2 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NC=N2 UAKLZWVXVMRJQS-UHFFFAOYSA-N 0.000 description 1
- FVRMFTUDYAUQFU-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NN=C2C1=CC=CC=C1 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)NN=C2C1=CC=CC=C1 FVRMFTUDYAUQFU-UHFFFAOYSA-N 0.000 description 1
- RARIUEAKERGROH-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C=NN(C)C2=O Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C=NN(C)C2=O RARIUEAKERGROH-UHFFFAOYSA-N 0.000 description 1
- HNEUETCDTSHRIO-UHFFFAOYSA-N CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=CC=NC(Cl)=C21 Chemical compound CC#CCN1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=CC=NC(Cl)=C21 HNEUETCDTSHRIO-UHFFFAOYSA-N 0.000 description 1
- DMVIQDKOTMDZSW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C#N)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C#N)=N2.O=C(O)C(F)(F)F DMVIQDKOTMDZSW-UHFFFAOYSA-N 0.000 description 1
- BYEPABWTWPLYTA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(=O)O)=N2.O=C(O)C(F)(F)F BYEPABWTWPLYTA-UHFFFAOYSA-N 0.000 description 1
- ZGMBTHCHEGGJEF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(=O)OC)=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(=O)OC)=C2.O=C(O)C(F)(F)F ZGMBTHCHEGGJEF-UHFFFAOYSA-N 0.000 description 1
- BDSCPTJYIXFHIH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(N)=O)=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(N)=O)=C2.O=C(O)C(F)(F)F BDSCPTJYIXFHIH-UHFFFAOYSA-N 0.000 description 1
- IWVBXYPLWJJKTJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(N)=O)=N2 Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C(N)=O)=N2 IWVBXYPLWJJKTJ-UHFFFAOYSA-N 0.000 description 1
- SKDFHXIIRPFURH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(C1=CC=CC=C1)=N2.O=C(O)C(F)(F)F SKDFHXIIRPFURH-UHFFFAOYSA-N 0.000 description 1
- ASCMARKCCSRSEY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CC(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CC(=O)OCC)=N2.O=C(O)C(F)(F)F ASCMARKCCSRSEY-UHFFFAOYSA-N 0.000 description 1
- JCVXEMRHKTZPLZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CC(C)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CC(C)=O)=N2.O=C(O)C(F)(F)F JCVXEMRHKTZPLZ-UHFFFAOYSA-N 0.000 description 1
- YTVJCOCFHAEIFZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F YTVJCOCFHAEIFZ-UHFFFAOYSA-N 0.000 description 1
- UWKYFXLPJDBWAF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F UWKYFXLPJDBWAF-UHFFFAOYSA-N 0.000 description 1
- PXNIRPXSEWIYFA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CCCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(CCCC)=N2.O=C(O)C(F)(F)F PXNIRPXSEWIYFA-UHFFFAOYSA-N 0.000 description 1
- WBPSQQFBZALLPS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C(C)=O)C(C)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C(C)=O)C(C)=O)=N2.O=C(O)C(F)(F)F WBPSQQFBZALLPS-UHFFFAOYSA-N 0.000 description 1
- OPSMVWSLYZGVOT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)C(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)C(C)C)=N2.O=C(O)C(F)(F)F OPSMVWSLYZGVOT-UHFFFAOYSA-N 0.000 description 1
- CQSHUZANBCZVDH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)C)=N2.O=C(O)C(F)(F)F CQSHUZANBCZVDH-UHFFFAOYSA-N 0.000 description 1
- PZORGOFAFOYBIO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)C1=CC=CC=C1C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)C1=CC=CC=C1C(=O)O)=N2.O=C(O)C(F)(F)F PZORGOFAFOYBIO-UHFFFAOYSA-N 0.000 description 1
- IWYPRKZDRXWZDN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC(=O)O)=N2.O=C(O)C(F)(F)F IWYPRKZDRXWZDN-UHFFFAOYSA-N 0.000 description 1
- QTAXFAHXYRDWKY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC(=O)OCC)=N2.O=C(O)C(F)(F)F QTAXFAHXYRDWKY-UHFFFAOYSA-N 0.000 description 1
- MVSHJUCQSLCARM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC)=N2.O=C(O)C(F)(F)F MVSHJUCQSLCARM-UHFFFAOYSA-N 0.000 description 1
- KEOIPUCMUPAOQD-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F KEOIPUCMUPAOQD-UHFFFAOYSA-N 0.000 description 1
- LQGSXJCOGZXCOE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(C)CCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F LQGSXJCOGZXCOE-UHFFFAOYSA-N 0.000 description 1
- NCNBOPSYDUSNAG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(CC)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N(CC)CC)=N2.O=C(O)C(F)(F)F NCNBOPSYDUSNAG-UHFFFAOYSA-N 0.000 description 1
- PDOLVQDHRSJAQV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N)=N2.O=C(O)C(F)(F)F PDOLVQDHRSJAQV-UHFFFAOYSA-N 0.000 description 1
- JEKYMEVCQKYTAL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC(C(=O)OCC)CC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC(C(=O)OCC)CC1)=N2.O=C(O)C(F)(F)F JEKYMEVCQKYTAL-UHFFFAOYSA-N 0.000 description 1
- LEASHAGNHSOYFO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCCC(C(=O)O)C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCCC(C(=O)O)C1)=N2.O=C(O)C(F)(F)F LEASHAGNHSOYFO-UHFFFAOYSA-N 0.000 description 1
- SIZLSEXLVCJBDW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCCC(C(=O)OCC)C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCCC(C(=O)OCC)C1)=N2.O=C(O)C(F)(F)F SIZLSEXLVCJBDW-UHFFFAOYSA-N 0.000 description 1
- WOCOJXYOQADFEB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCCCC1C(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCCCC1C(=O)OCC)=N2.O=C(O)C(F)(F)F WOCOJXYOQADFEB-UHFFFAOYSA-N 0.000 description 1
- SIZLSEXLVCJBDW-MRXNPFEDSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@@H](C(=O)OCC)C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@@H](C(=O)OCC)C1)=N2.O=C(O)C(F)(F)F SIZLSEXLVCJBDW-MRXNPFEDSA-N 0.000 description 1
- ZHDIRWCCJNNHOU-CYBMUJFWSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@@H]1C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@@H]1C(=O)O)=N2.O=C(O)C(F)(F)F ZHDIRWCCJNNHOU-CYBMUJFWSA-N 0.000 description 1
- GGUHYEXVEHRBRG-CQSZACIVSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@@H]1C(=O)OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@@H]1C(=O)OC)=N2.O=C(O)C(F)(F)F GGUHYEXVEHRBRG-CQSZACIVSA-N 0.000 description 1
- SIZLSEXLVCJBDW-INIZCTEOSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@H](C(=O)OCC)C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@H](C(=O)OCC)C1)=N2.O=C(O)C(F)(F)F SIZLSEXLVCJBDW-INIZCTEOSA-N 0.000 description 1
- GGUHYEXVEHRBRG-AWEZNQCLSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@H]1C(=O)OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCC[C@H]1C(=O)OC)=N2.O=C(O)C(F)(F)F GGUHYEXVEHRBRG-AWEZNQCLSA-N 0.000 description 1
- HQZNJFFLBAAHGT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCOCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCOCC1)=N2.O=C(O)C(F)(F)F HQZNJFFLBAAHGT-UHFFFAOYSA-N 0.000 description 1
- FKTZSQLYNWLQTL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCSCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N1CCSCC1)=N2.O=C(O)C(F)(F)F FKTZSQLYNWLQTL-UHFFFAOYSA-N 0.000 description 1
- XOSZWSGDMVATJG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)(C)C(=O)OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)(C)C(=O)OC)=N2.O=C(O)C(F)(F)F XOSZWSGDMVATJG-UHFFFAOYSA-N 0.000 description 1
- RQPPIVGLJOXBDB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)=O)=N2.O=C(O)C(F)(F)F RQPPIVGLJOXBDB-UHFFFAOYSA-N 0.000 description 1
- FBDODIPQMCWKDJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)C(=O)O)=N2.O=C(O)C(F)(F)F FBDODIPQMCWKDJ-UHFFFAOYSA-N 0.000 description 1
- XAOKQYSDMVDUDH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)C(=O)OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)C(=O)OC)=N2.O=C(O)C(F)(F)F XAOKQYSDMVDUDH-UHFFFAOYSA-N 0.000 description 1
- APYRCUBXYXNCGA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC(C)C)=N2.O=C(O)C(F)(F)F APYRCUBXYXNCGA-UHFFFAOYSA-N 0.000 description 1
- PWGRAJDHETXTGK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=C(C(N)=O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=C(C(N)=O)C=C1)=N2.O=C(O)C(F)(F)F PWGRAJDHETXTGK-UHFFFAOYSA-N 0.000 description 1
- SKSYPPCHAAHARZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F SKSYPPCHAAHARZ-UHFFFAOYSA-N 0.000 description 1
- QDMBACBOWVQBOZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1C(=O)NC(C)(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1C(=O)NC(C)(C)C)=N2.O=C(O)C(F)(F)F QDMBACBOWVQBOZ-UHFFFAOYSA-N 0.000 description 1
- GVEBXPZQIUWUCK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F GVEBXPZQIUWUCK-UHFFFAOYSA-N 0.000 description 1
- HDNKTUHNGAUVAK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1S(N)(=O)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=C1S(N)(=O)=O)=N2.O=C(O)C(F)(F)F HDNKTUHNGAUVAK-UHFFFAOYSA-N 0.000 description 1
- SPLVKIJRZYGDAR-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NC1=CC=CC=N1)=N2.O=C(O)C(F)(F)F SPLVKIJRZYGDAR-UHFFFAOYSA-N 0.000 description 1
- XABUCHALHAADFS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC(=O)O)=N2.O=C(O)C(F)(F)F XABUCHALHAADFS-UHFFFAOYSA-N 0.000 description 1
- ULDCTWHDUXQNSP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=CC=C(Cl)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=CC=C(Cl)C=C1)=N2.O=C(O)C(F)(F)F ULDCTWHDUXQNSP-UHFFFAOYSA-N 0.000 description 1
- PAYZDHDCVGTTLM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=CC=C(OC)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=CC=C(OC)C=C1)=N2.O=C(O)C(F)(F)F PAYZDHDCVGTTLM-UHFFFAOYSA-N 0.000 description 1
- KXRIFXBDAWHOGC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F KXRIFXBDAWHOGC-UHFFFAOYSA-N 0.000 description 1
- DSJMDCSOGBRCGQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=NC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCC1=NC=CC=C1)=N2.O=C(O)C(F)(F)F DSJMDCSOGBRCGQ-UHFFFAOYSA-N 0.000 description 1
- ZLPZNCPYDRIZRU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCCC(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCCC(=O)OCC)=N2.O=C(O)C(F)(F)F ZLPZNCPYDRIZRU-UHFFFAOYSA-N 0.000 description 1
- GMJRGTZMKDTVSI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(NCCC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F GMJRGTZMKDTVSI-UHFFFAOYSA-N 0.000 description 1
- FBDODIPQMCWKDJ-NSHDSACASA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N[C@@H](C)C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N[C@@H](C)C(=O)O)=N2.O=C(O)C(F)(F)F FBDODIPQMCWKDJ-NSHDSACASA-N 0.000 description 1
- MSXRHQJAVGGGIT-ZDUSSCGKSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N[C@@H](C)C(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(N[C@@H](C)C(=O)OCC)=N2.O=C(O)C(F)(F)F MSXRHQJAVGGGIT-ZDUSSCGKSA-N 0.000 description 1
- LHZNQRGNMPFJNN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C(=O)OC)C1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C(=O)OC)C1=CC=CC=C1)=N2.O=C(O)C(F)(F)F LHZNQRGNMPFJNN-UHFFFAOYSA-N 0.000 description 1
- PKDMCEHHBROANX-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)C(=O)O)=N2.O=C(O)C(F)(F)F PKDMCEHHBROANX-UHFFFAOYSA-N 0.000 description 1
- KTLJNFXYJFBYKC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)C(=O)OCC)=N2 Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)C(=O)OCC)=N2 KTLJNFXYJFBYKC-UHFFFAOYSA-N 0.000 description 1
- NVQMZGLZOSAJCF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)C)=N2.O=C(O)C(F)(F)F NVQMZGLZOSAJCF-UHFFFAOYSA-N 0.000 description 1
- ZVGKZYPNJSRYQJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC(C)CC)=N2.O=C(O)C(F)(F)F ZVGKZYPNJSRYQJ-UHFFFAOYSA-N 0.000 description 1
- OWJLZCSYJKUBPN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC)=N2.O=C(O)C(F)(F)F OWJLZCSYJKUBPN-UHFFFAOYSA-N 0.000 description 1
- QBRTVOZQCRUWGN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1(C(=O)O)CC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1(C(=O)O)CC1)=N2.O=C(O)C(F)(F)F QBRTVOZQCRUWGN-UHFFFAOYSA-N 0.000 description 1
- GEEPYIMQTAHFDQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1(C(=O)OCC)CC1)=N2 Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1(C(=O)OCC)CC1)=N2 GEEPYIMQTAHFDQ-UHFFFAOYSA-N 0.000 description 1
- IKXGZXBITMNJMU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1(C(N)=O)CC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1(C(N)=O)CC1)=N2.O=C(O)C(F)(F)F IKXGZXBITMNJMU-UHFFFAOYSA-N 0.000 description 1
- ORMUUKUXXHFRNQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(C)C=C(C(=O)O)C=C1C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(C)C=C(C(=O)O)C=C1C)=N2.O=C(O)C(F)(F)F ORMUUKUXXHFRNQ-UHFFFAOYSA-N 0.000 description 1
- FSZVTOSWFWVZFM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(CC(=O)O)C=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=C(CC(=O)O)C=CC=C1)=N2.O=C(O)C(F)(F)F FSZVTOSWFWVZFM-UHFFFAOYSA-N 0.000 description 1
- BPMBYGSYUCJGEK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(=O)N3CCCC3)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(=O)N3CCCC3)C=C1)=N2.O=C(O)C(F)(F)F BPMBYGSYUCJGEK-UHFFFAOYSA-N 0.000 description 1
- KDKDJWIFAGMWRX-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(=O)O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(=O)O)C=C1)=N2.O=C(O)C(F)(F)F KDKDJWIFAGMWRX-UHFFFAOYSA-N 0.000 description 1
- IMWOFJFLLPWZRL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(=O)O)C=C1F)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(=O)O)C=C1F)=N2.O=C(O)C(F)(F)F IMWOFJFLLPWZRL-UHFFFAOYSA-N 0.000 description 1
- FGLNDHHKVPOAKW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(C)=O)C=C1C(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(C)=O)C=C1C(N)=O)=N2.O=C(O)C(F)(F)F FGLNDHHKVPOAKW-UHFFFAOYSA-N 0.000 description 1
- JUKDUISAEMUHRS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(N)=O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C(N)=O)C=C1)=N2.O=C(O)C(F)(F)F JUKDUISAEMUHRS-UHFFFAOYSA-N 0.000 description 1
- DTSWEYLTKKGHRE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(C)C=C1)=N2.O=C(O)C(F)(F)F DTSWEYLTKKGHRE-UHFFFAOYSA-N 0.000 description 1
- CLTIJHYSCINDEF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(CC(=O)O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(CC(=O)O)C=C1)=N2.O=C(O)C(F)(F)F CLTIJHYSCINDEF-UHFFFAOYSA-N 0.000 description 1
- ZUBDORRYULXWIQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(NC(C)=O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(NC(C)=O)C=C1)=N2.O=C(O)C(F)(F)F ZUBDORRYULXWIQ-UHFFFAOYSA-N 0.000 description 1
- UZJMOFBYEPCKPY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(OC)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(OC)C=C1)=N2.O=C(O)C(F)(F)F UZJMOFBYEPCKPY-UHFFFAOYSA-N 0.000 description 1
- QINZYMBSJUVMMZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(S(N)(=O)=O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=C(S(N)(=O)=O)C=C1)=N2.O=C(O)C(F)(F)F QINZYMBSJUVMMZ-UHFFFAOYSA-N 0.000 description 1
- OQKJDJPEUXQEEC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(C(=O)O)=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(C(=O)O)=C1)=N2.O=C(O)C(F)(F)F OQKJDJPEUXQEEC-UHFFFAOYSA-N 0.000 description 1
- TTWWHBQCIBCWSO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(C)=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(C)=C1)=N2.O=C(O)C(F)(F)F TTWWHBQCIBCWSO-UHFFFAOYSA-N 0.000 description 1
- XEJWBQBNCNNBAF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(NC(C)=O)=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(NC(C)=O)=C1)=N2.O=C(O)C(F)(F)F XEJWBQBNCNNBAF-UHFFFAOYSA-N 0.000 description 1
- VZAZRULWZXKGBP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(OC)=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC(OC)=C1)=N2.O=C(O)C(F)(F)F VZAZRULWZXKGBP-UHFFFAOYSA-N 0.000 description 1
- AOVAUTPHHKXDII-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F AOVAUTPHHKXDII-UHFFFAOYSA-N 0.000 description 1
- JDCRNYZVIDLGQU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C#N)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C#N)=N2.O=C(O)C(F)(F)F JDCRNYZVIDLGQU-UHFFFAOYSA-N 0.000 description 1
- KWQGEECGYZQYPX-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N(C)C)=N2.O=C(O)C(F)(F)F KWQGEECGYZQYPX-UHFFFAOYSA-N 0.000 description 1
- KKFBAPPCKPDSGG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N1CCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N1CCCC1)=N2.O=C(O)C(F)(F)F KKFBAPPCKPDSGG-UHFFFAOYSA-N 0.000 description 1
- DCEMHSSSSGLZHI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N1CCOCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N1CCOCC1)=N2.O=C(O)C(F)(F)F DCEMHSSSSGLZHI-UHFFFAOYSA-N 0.000 description 1
- YTTALHJLAZEREE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N1CCSC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)N1CCSC1)=N2.O=C(O)C(F)(F)F YTTALHJLAZEREE-UHFFFAOYSA-N 0.000 description 1
- PNFIRSOOIIWFRK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)NCCN1CCCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(=O)NCCN1CCCCC1)=N2.O=C(O)C(F)(F)F PNFIRSOOIIWFRK-UHFFFAOYSA-N 0.000 description 1
- QGYDSLGNQOBQFQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(C)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C(C)=O)=N2.O=C(O)C(F)(F)F QGYDSLGNQOBQFQ-UHFFFAOYSA-N 0.000 description 1
- LTVGCHHDEHXPTM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1C)=N2.O=C(O)C(F)(F)F LTVGCHHDEHXPTM-UHFFFAOYSA-N 0.000 description 1
- JTVSOHPOMGZRBC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1OC)=N2.O=C(O)C(F)(F)F JTVSOHPOMGZRBC-UHFFFAOYSA-N 0.000 description 1
- GDRMNEJTBYRYJA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1SC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CC=C1SC)=N2.O=C(O)C(F)(F)F GDRMNEJTBYRYJA-UHFFFAOYSA-N 0.000 description 1
- HGWAUWXBJCKBEV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CN=C1C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CN=C1C(=O)O)=N2.O=C(O)C(F)(F)F HGWAUWXBJCKBEV-UHFFFAOYSA-N 0.000 description 1
- YOTHNOJGUGBOAO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CN=C1C(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=CC=CN=C1C(N)=O)=N2.O=C(O)C(F)(F)F YOTHNOJGUGBOAO-UHFFFAOYSA-N 0.000 description 1
- FIXCXRRXODETDH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=NC(C)=CC(C)=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=NC(C)=CC(C)=N1)=N2.O=C(O)C(F)(F)F FIXCXRRXODETDH-UHFFFAOYSA-N 0.000 description 1
- PHZLPCWOIOMBPL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=NC=CC(C(N)=O)=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1=NC=CC(C(N)=O)=N1)=N2.O=C(O)C(F)(F)F PHZLPCWOIOMBPL-UHFFFAOYSA-N 0.000 description 1
- GRJKEQMSVGXFGT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1CCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1CCCC1)=N2.O=C(O)C(F)(F)F GRJKEQMSVGXFGT-UHFFFAOYSA-N 0.000 description 1
- FQLOEKYECWASSO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1CCCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OC1CCCCC1)=N2.O=C(O)C(F)(F)F FQLOEKYECWASSO-UHFFFAOYSA-N 0.000 description 1
- KGEUIVVNFRMYMN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC(=O)O)=N2.O=C(O)C(F)(F)F KGEUIVVNFRMYMN-UHFFFAOYSA-N 0.000 description 1
- BPKWPOQMUZRSND-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC(=O)OCC)=N2 Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC(=O)OCC)=N2 BPKWPOQMUZRSND-UHFFFAOYSA-N 0.000 description 1
- FEUSIMLGQPEQDH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC)=N2 Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC)=N2 FEUSIMLGQPEQDH-UHFFFAOYSA-N 0.000 description 1
- MUQNWXZHLSMLFV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC1=NC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(OCC1=NC=CC=C1)=N2.O=C(O)C(F)(F)F MUQNWXZHLSMLFV-UHFFFAOYSA-N 0.000 description 1
- BTJFDUZHOVALCP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S(=O)(=O)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S(=O)(=O)CC)=N2.O=C(O)C(F)(F)F BTJFDUZHOVALCP-UHFFFAOYSA-N 0.000 description 1
- DEKJLYDCOVRVLQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S(=O)C(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S(=O)C(C)C)=N2.O=C(O)C(F)(F)F DEKJLYDCOVRVLQ-UHFFFAOYSA-N 0.000 description 1
- ZBKYFLPNQCQRRS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S(=O)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S(=O)CC)=N2.O=C(O)C(F)(F)F ZBKYFLPNQCQRRS-UHFFFAOYSA-N 0.000 description 1
- KOFSFDPGFKABIO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(S)=N2.O=C(O)C(F)(F)F KOFSFDPGFKABIO-UHFFFAOYSA-N 0.000 description 1
- BBQXCLJCPUQMMO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)(C)C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)(C)C(=O)O)=N2.O=C(O)C(F)(F)F BBQXCLJCPUQMMO-UHFFFAOYSA-N 0.000 description 1
- DPLMSOITCZTOEU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)(C)C)=N2.O=C(O)C(F)(F)F DPLMSOITCZTOEU-UHFFFAOYSA-N 0.000 description 1
- KCDCGBSIFIPVEJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C(=O)OCC)=N2.O=C(O)C(F)(F)F KCDCGBSIFIPVEJ-UHFFFAOYSA-N 0.000 description 1
- QPJNSBBSUQAFED-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C(C)C)=N2.O=C(O)C(F)(F)F QPJNSBBSUQAFED-UHFFFAOYSA-N 0.000 description 1
- XRHVPFUYANDKQT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C)=N2.O=C(O)C(F)(F)F XRHVPFUYANDKQT-UHFFFAOYSA-N 0.000 description 1
- KCLMODLPFSHWFL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C1=CC=CS1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)C1=CC=CS1)=N2.O=C(O)C(F)(F)F KCLMODLPFSHWFL-UHFFFAOYSA-N 0.000 description 1
- XQYLEIRXPYBKKB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)CC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC(C)CC)=N2.O=C(O)C(F)(F)F XQYLEIRXPYBKKB-UHFFFAOYSA-N 0.000 description 1
- ZBXZQWDKDMKZML-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC)=N2.O=C(O)C(F)(F)F ZBXZQWDKDMKZML-UHFFFAOYSA-N 0.000 description 1
- AWVNTHSCGMVCCI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=C(OC)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=C(OC)C=C1)=N2.O=C(O)C(F)(F)F AWVNTHSCGMVCCI-UHFFFAOYSA-N 0.000 description 1
- JZWTYDYEXGXDTG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=C([N+](=O)[O-])C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=C([N+](=O)[O-])C=C1)=N2.O=C(O)C(F)(F)F JZWTYDYEXGXDTG-UHFFFAOYSA-N 0.000 description 1
- JUIYBWJUHAQCIL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CC=C1)=N2.O=C(O)C(F)(F)F JUIYBWJUHAQCIL-UHFFFAOYSA-N 0.000 description 1
- CAJYLVQXZJZUIG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CC=C1C(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CC=C1C(=O)OCC)=N2.O=C(O)C(F)(F)F CAJYLVQXZJZUIG-UHFFFAOYSA-N 0.000 description 1
- KMJVCSCYIXMCRY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CC=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CC=N1)=N2.O=C(O)C(F)(F)F KMJVCSCYIXMCRY-UHFFFAOYSA-N 0.000 description 1
- WSSJDRDBLNARKC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CS1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=CS1)=N2.O=C(O)C(F)(F)F WSSJDRDBLNARKC-UHFFFAOYSA-N 0.000 description 1
- OGKBJEOVGZHSJH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=NC=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=CC=NC=C1)=N2.O=C(O)C(F)(F)F OGKBJEOVGZHSJH-UHFFFAOYSA-N 0.000 description 1
- KECRDGVRYGYRGE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC(C)=CC(C)=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC(C)=CC(C)=N1)=N2.O=C(O)C(F)(F)F KECRDGVRYGYRGE-UHFFFAOYSA-N 0.000 description 1
- GFGCZBMYGPTOKW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC(C)=CS1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC(C)=CS1)=N2.O=C(O)C(F)(F)F GFGCZBMYGPTOKW-UHFFFAOYSA-N 0.000 description 1
- NQCGJNAGGGXLOP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC3=C(C=CC=C3)N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC3=C(C=CC=C3)N1)=N2.O=C(O)C(F)(F)F NQCGJNAGGGXLOP-UHFFFAOYSA-N 0.000 description 1
- HMXVXGRWZYZCQC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC3=C(C=CC=C3)O1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC3=C(C=CC=C3)O1)=N2.O=C(O)C(F)(F)F HMXVXGRWZYZCQC-UHFFFAOYSA-N 0.000 description 1
- SAOMDBPCWHAGHI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC3=C(C=CC=C3)S1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC3=C(C=CC=C3)S1)=N2.O=C(O)C(F)(F)F SAOMDBPCWHAGHI-UHFFFAOYSA-N 0.000 description 1
- VUZLOYFXPBBBKW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=C(C(=O)O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=C(C(=O)O)C=C1)=N2.O=C(O)C(F)(F)F VUZLOYFXPBBBKW-UHFFFAOYSA-N 0.000 description 1
- HSEOEMMKCSDNEZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CN1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CN1)=N2.O=C(O)C(F)(F)F HSEOEMMKCSDNEZ-UHFFFAOYSA-N 0.000 description 1
- RYLKYZHREXZHJE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CN1C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CN1C)=N2.O=C(O)C(F)(F)F RYLKYZHREXZHJE-UHFFFAOYSA-N 0.000 description 1
- MZTOWGLUJZIAAO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CS1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NC=CS1)=N2.O=C(O)C(F)(F)F MZTOWGLUJZIAAO-UHFFFAOYSA-N 0.000 description 1
- ZAYGJBANRUAMDP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NN=C(C)S1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NN=C(C)S1)=N2.O=C(O)C(F)(F)F ZAYGJBANRUAMDP-UHFFFAOYSA-N 0.000 description 1
- ZQEHAWZEZRZSBV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NNC=N1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=NNC=N1)=N2.O=C(O)C(F)(F)F ZQEHAWZEZRZSBV-UHFFFAOYSA-N 0.000 description 1
- GQYUBVAMPPAKRG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=[SH]C(N)=NN1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1=[SH]C(N)=NN1)=N2.O=C(O)C(F)(F)F GQYUBVAMPPAKRG-UHFFFAOYSA-N 0.000 description 1
- IPHGFVRCHMWFDL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1CCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1CCCC1)=N2.O=C(O)C(F)(F)F IPHGFVRCHMWFDL-UHFFFAOYSA-N 0.000 description 1
- KIPICQCUKQFWMS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1CCCCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC1CCCCC1)=N2.O=C(O)C(F)(F)F KIPICQCUKQFWMS-UHFFFAOYSA-N 0.000 description 1
- HODBVNBZRNVMNA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(=O)O)=N2.O=C(O)C(F)(F)F HODBVNBZRNVMNA-UHFFFAOYSA-N 0.000 description 1
- UCAVESGJHLPZOF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(=O)OC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(=O)OC)=N2.O=C(O)C(F)(F)F UCAVESGJHLPZOF-UHFFFAOYSA-N 0.000 description 1
- QKEMNXRNINVBTI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(C)C)=N2.O=C(O)C(F)(F)F QKEMNXRNINVBTI-UHFFFAOYSA-N 0.000 description 1
- JGNRLIOFZKQVPW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(C)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(C)O)=N2.O=C(O)C(F)(F)F JGNRLIOFZKQVPW-UHFFFAOYSA-N 0.000 description 1
- SVPAYNWJRLLWOV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(N)=O)=N2.O=C(O)C(F)(F)F SVPAYNWJRLLWOV-UHFFFAOYSA-N 0.000 description 1
- TURBWHPCJZRTNF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(O)CO)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC(O)CO)=N2.O=C(O)C(F)(F)F TURBWHPCJZRTNF-UHFFFAOYSA-N 0.000 description 1
- KOZRTWVJGGSQMS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC)=N2.O=C(O)C(F)(F)F KOZRTWVJGGSQMS-UHFFFAOYSA-N 0.000 description 1
- GZHSLWMSNFBGFY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC1=CC=CO1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC1=CC=CO1)=N2.O=C(O)C(F)(F)F GZHSLWMSNFBGFY-UHFFFAOYSA-N 0.000 description 1
- JEIRGEGHCVVUJU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC1=CC=CS1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCC1=CC=CS1)=N2.O=C(O)C(F)(F)F JEIRGEGHCVVUJU-UHFFFAOYSA-N 0.000 description 1
- CEGNOFUEKJYNFH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCC(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCC(=O)O)=N2.O=C(O)C(F)(F)F CEGNOFUEKJYNFH-UHFFFAOYSA-N 0.000 description 1
- SMAAMYDRLWELHP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCC(=O)OCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCC(=O)OCC)=N2.O=C(O)C(F)(F)F SMAAMYDRLWELHP-UHFFFAOYSA-N 0.000 description 1
- LJUFDHLLKIKCGP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCC)=N2.O=C(O)C(F)(F)F LJUFDHLLKIKCGP-UHFFFAOYSA-N 0.000 description 1
- FETISJHDMYGXGA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCCCCCCCCCCC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCCCCCCCCCCC)=N2.O=C(O)C(F)(F)F FETISJHDMYGXGA-UHFFFAOYSA-N 0.000 description 1
- QPMBJZIKKZZUIW-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCCO)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCCO)=N2.O=C(O)C(F)(F)F QPMBJZIKKZZUIW-UHFFFAOYSA-N 0.000 description 1
- BCFYAKOQZQDZBE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCN)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCN)=N2.O=C(O)C(F)(F)F BCFYAKOQZQDZBE-UHFFFAOYSA-N 0.000 description 1
- AAFIUNLZLPFKQF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCNC(C)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCNC(C)=O)=N2.O=C(O)C(F)(F)F AAFIUNLZLPFKQF-UHFFFAOYSA-N 0.000 description 1
- MQJAMVMNZMMJPV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCO)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SCCO)=N2.O=C(O)C(F)(F)F MQJAMVMNZMMJPV-UHFFFAOYSA-N 0.000 description 1
- UTXYKOVHJWNFCC-NSHDSACASA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC[C@H](N)C(=O)O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C(SC[C@H](N)C(=O)O)=N2.O=C(O)C(F)(F)F UTXYKOVHJWNFCC-NSHDSACASA-N 0.000 description 1
- WYFONLBZXVYUTR-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C=C2.O=C(O)C(F)(F)F WYFONLBZXVYUTR-UHFFFAOYSA-N 0.000 description 1
- YJLNJUWSFYKXED-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)C=N2.O=C(O)C(F)(F)F YJLNJUWSFYKXED-UHFFFAOYSA-N 0.000 description 1
- FJSRCOFPVBULHR-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C#N.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C#N.O=C(O)C(F)(F)F FJSRCOFPVBULHR-UHFFFAOYSA-N 0.000 description 1
- OMIDRNXYPSQYDL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C(F)(F)F.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C(F)(F)F.O=C(O)C(F)(F)F OMIDRNXYPSQYDL-UHFFFAOYSA-N 0.000 description 1
- WIGROSOOAZKFDK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C(N)=O.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C(N)=O.O=C(O)C(F)(F)F WIGROSOOAZKFDK-UHFFFAOYSA-N 0.000 description 1
- MCHIJTHVBSFTPY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C.O=C(O)C(F)(F)F MCHIJTHVBSFTPY-UHFFFAOYSA-N 0.000 description 1
- BXEWXSXZPVNAEB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C1=CC=CC=C1.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2C1=CC=CC=C1.O=C(O)C(F)(F)F BXEWXSXZPVNAEB-UHFFFAOYSA-N 0.000 description 1
- AWDDPTWMPJJYBZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2N(C)C.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2N(C)C.O=C(O)C(F)(F)F AWDDPTWMPJJYBZ-UHFFFAOYSA-N 0.000 description 1
- GZQIFSGNRFFIFJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC#N)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC#N)N=C2.O=C(O)C(F)(F)F GZQIFSGNRFFIFJ-UHFFFAOYSA-N 0.000 description 1
- CEHQXBFVBZGFLA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=C(C#N)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=C(C#N)C=C1)N=C2.O=C(O)C(F)(F)F CEHQXBFVBZGFLA-UHFFFAOYSA-N 0.000 description 1
- PLVWXXCTCUQPCK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=C(OC)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=C(OC)C=C1)N=C2.O=C(O)C(F)(F)F PLVWXXCTCUQPCK-UHFFFAOYSA-N 0.000 description 1
- ZEXWZHQKRIWRGP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC(OC)=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC(OC)=C1)N=C2.O=C(O)C(F)(F)F ZEXWZHQKRIWRGP-UHFFFAOYSA-N 0.000 description 1
- UXETVFOMOCIQBY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1)C(C(=O)OC)=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1)C(C(=O)OC)=C2.O=C(O)C(F)(F)F UXETVFOMOCIQBY-UHFFFAOYSA-N 0.000 description 1
- TVXZHCGZKOKCMC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1)C=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1)C=C2.O=C(O)C(F)(F)F TVXZHCGZKOKCMC-UHFFFAOYSA-N 0.000 description 1
- WVIMFOJEAUJELN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F WVIMFOJEAUJELN-UHFFFAOYSA-N 0.000 description 1
- CNAVPICKGVAMBV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1OC)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1OC)N=C2.O=C(O)C(F)(F)F CNAVPICKGVAMBV-UHFFFAOYSA-N 0.000 description 1
- PEIQDICRKYFXNY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1[N+](=O)[O-])N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)C1=CC=CC=C1[N+](=O)[O-])N=C2.O=C(O)C(F)(F)F PEIQDICRKYFXNY-UHFFFAOYSA-N 0.000 description 1
- YMYSFTQNKZONBJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)O)N=C2C1=CC=CC=C1.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)O)N=C2C1=CC=CC=C1.O=C(O)C(F)(F)F YMYSFTQNKZONBJ-UHFFFAOYSA-N 0.000 description 1
- YFNDGLHDOVWVHP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)OCC)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC(=O)OCC)N=C2.O=C(O)C(F)(F)F YFNDGLHDOVWVHP-UHFFFAOYSA-N 0.000 description 1
- NENDBTYBMGBKDH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C=C1C#N)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C=C1C#N)N=C2.O=C(O)C(F)(F)F NENDBTYBMGBKDH-UHFFFAOYSA-N 0.000 description 1
- OMDVAQWSBZLBTO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C=C1F)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C=C1F)N=C2.O=C(O)C(F)(F)F OMDVAQWSBZLBTO-UHFFFAOYSA-N 0.000 description 1
- BISMMTLRNAZJNK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C=C1OCC)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(C(=O)NC)C=C1OCC)N=C2.O=C(O)C(F)(F)F BISMMTLRNAZJNK-UHFFFAOYSA-N 0.000 description 1
- SUZOKEYFLBTJSL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(F)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=C(F)C=C1)N=C2.O=C(O)C(F)(F)F SUZOKEYFLBTJSL-UHFFFAOYSA-N 0.000 description 1
- VDKBBVCVOXKQDJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)C=C2.O=C(O)C(F)(F)F VDKBBVCVOXKQDJ-UHFFFAOYSA-N 0.000 description 1
- HMFYVRLLPZSBFN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)N=C2.O=C(O)C(F)(F)F HMFYVRLLPZSBFN-UHFFFAOYSA-N 0.000 description 1
- BBMKTLOITHOJHS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)N=C2C1=CC=CC=C1.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1)N=C2C1=CC=CC=C1.O=C(O)C(F)(F)F BBMKTLOITHOJHS-UHFFFAOYSA-N 0.000 description 1
- FIBRDUVLNFPOSL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1F)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C#N)C=CC=C1F)N=C2.O=C(O)C(F)(F)F FIBRDUVLNFPOSL-UHFFFAOYSA-N 0.000 description 1
- FMTPQHSCVSVCSU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C(F)(F)F)C=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C(F)(F)F)C=CC=C1)N=C2.O=C(O)C(F)(F)F FMTPQHSCVSVCSU-UHFFFAOYSA-N 0.000 description 1
- WFBXMTZIRHMOLI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C(N)=O)C=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(C(N)=O)C=CC=C1)N=C2.O=C(O)C(F)(F)F WFBXMTZIRHMOLI-UHFFFAOYSA-N 0.000 description 1
- SXAQTCBXOHUKLM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(F)C=C(C#N)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(F)C=C(C#N)C=C1)N=C2.O=C(O)C(F)(F)F SXAQTCBXOHUKLM-UHFFFAOYSA-N 0.000 description 1
- NNUFNQYSYRJFSC-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(F)N=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(F)N=CC=C1)N=C2.O=C(O)C(F)(F)F NNUFNQYSYRJFSC-UHFFFAOYSA-N 0.000 description 1
- KWOIKDMXZPUCBV-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(OC)N=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C(OC)N=CC=C1)N=C2.O=C(O)C(F)(F)F KWOIKDMXZPUCBV-UHFFFAOYSA-N 0.000 description 1
- RZDYJGJBWWNNJI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C([N+](=O)[O-])C=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C([N+](=O)[O-])C=CC=C1)N=C2.O=C(O)C(F)(F)F RZDYJGJBWWNNJI-UHFFFAOYSA-N 0.000 description 1
- JOADTMMRJSUOHD-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C3C=CC=CC3=CC=N1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=C3C=CC=CC3=CC=N1)N=C2.O=C(O)C(F)(F)F JOADTMMRJSUOHD-UHFFFAOYSA-N 0.000 description 1
- SFJKPPBPQFCOBX-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C#N)=C(F)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C#N)=C(F)C=C1)N=C2.O=C(O)C(F)(F)F SFJKPPBPQFCOBX-UHFFFAOYSA-N 0.000 description 1
- HNGZDAFBADVQQR-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C#N)=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C#N)=CC=C1)N=C2.O=C(O)C(F)(F)F HNGZDAFBADVQQR-UHFFFAOYSA-N 0.000 description 1
- MUMRMXYVAKWERU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(=O)O)=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(=O)O)=CC=C1)N=C2.O=C(O)C(F)(F)F MUMRMXYVAKWERU-UHFFFAOYSA-N 0.000 description 1
- YLKBHLDOWXZLGN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(F)(F)F)=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(F)(F)F)=CC=C1)N=C2.O=C(O)C(F)(F)F YLKBHLDOWXZLGN-UHFFFAOYSA-N 0.000 description 1
- COYOKBUUYRREPB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(N)=O)=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(C(N)=O)=CC=C1)N=C2.O=C(O)C(F)(F)F COYOKBUUYRREPB-UHFFFAOYSA-N 0.000 description 1
- LILYDUPIAPBIKH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(F)=NC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC(F)=NC=C1)N=C2.O=C(O)C(F)(F)F LILYDUPIAPBIKH-UHFFFAOYSA-N 0.000 description 1
- CJRHALSQOOYHRB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)C(SC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)C(SC)=N2.O=C(O)C(F)(F)F CJRHALSQOOYHRB-UHFFFAOYSA-N 0.000 description 1
- RWOSFTOLGNQFJT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C#N)C=C1)N=C2.O=C(O)C(F)(F)F RWOSFTOLGNQFJT-UHFFFAOYSA-N 0.000 description 1
- KRALNPNZYDBLJL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)O)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)O)C=C1)N=C2.O=C(O)C(F)(F)F KRALNPNZYDBLJL-UHFFFAOYSA-N 0.000 description 1
- PJAKAOBUBUGMMQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)OC)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)OC)C=C1)N=C2.O=C(O)C(F)(F)F PJAKAOBUBUGMMQ-UHFFFAOYSA-N 0.000 description 1
- PKHRFQDOKJKVIK-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)OCC)O1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(=O)OCC)O1)N=C2.O=C(O)C(F)(F)F PKHRFQDOKJKVIK-UHFFFAOYSA-N 0.000 description 1
- BIOKNAQVHPYYQS-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(N)=O)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=C(C(N)=O)C=C1)N=C2.O=C(O)C(F)(F)F BIOKNAQVHPYYQS-UHFFFAOYSA-N 0.000 description 1
- WKWBILNVBPDLGA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(C(=O)OC)=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(C(=O)OC)=C2.O=C(O)C(F)(F)F WKWBILNVBPDLGA-UHFFFAOYSA-N 0.000 description 1
- HFKLXOGDNYTQMQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(C(N)=O)=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(C(N)=O)=C2.O=C(O)C(F)(F)F HFKLXOGDNYTQMQ-UHFFFAOYSA-N 0.000 description 1
- VITOHVZLPDEOKO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(OC)=N2.[H]Cl VITOHVZLPDEOKO-UHFFFAOYSA-N 0.000 description 1
- WBYRHLYSTVIGMY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(SCC(=O)OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=CC=CC=C1C#N)C(SCC(=O)OC)=N2.[H]Cl WBYRHLYSTVIGMY-UHFFFAOYSA-N 0.000 description 1
- FYDREJUYKPFPRM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC(F)=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC(F)=CC=C1)N=C2.O=C(O)C(F)(F)F FYDREJUYKPFPRM-UHFFFAOYSA-N 0.000 description 1
- NBXXWUQEAKHDSG-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC=C(N)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CC1=NC=C(N)C=C1)N=C2.O=C(O)C(F)(F)F NBXXWUQEAKHDSG-UHFFFAOYSA-N 0.000 description 1
- VZPRYZORHCIQFT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=C(C(=O)O)C=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=C(C(=O)O)C=C1)N=C2.O=C(O)C(F)(F)F VZPRYZORHCIQFT-UHFFFAOYSA-N 0.000 description 1
- CRHKASZZPPLOKY-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(N(C)C)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(N(C)C)=N2.[H]Cl CRHKASZZPPLOKY-UHFFFAOYSA-N 0.000 description 1
- SNGQHRNKAXHQED-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(NCC(N)=O)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(NCC(N)=O)=N2.[H]Cl SNGQHRNKAXHQED-UHFFFAOYSA-N 0.000 description 1
- HFIFWKUHGLCHPP-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OC)=N2.[H]Cl HFIFWKUHGLCHPP-UHFFFAOYSA-N 0.000 description 1
- UMPWMTPCFMLVCL-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OCC(=O)OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OCC(=O)OC)=N2.[H]Cl UMPWMTPCFMLVCL-UHFFFAOYSA-N 0.000 description 1
- LHBJDEHMEBAGKU-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OCCO)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(OCCO)=N2.[H]Cl LHBJDEHMEBAGKU-UHFFFAOYSA-N 0.000 description 1
- KIRDADIWXMTOFQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(SCC(=O)OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(SCC(=O)OC)=N2.[H]Cl KIRDADIWXMTOFQ-UHFFFAOYSA-N 0.000 description 1
- KVNMYULPYGGEOT-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(SCC(=O)OCC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C(SCC(=O)OCC)=N2.[H]Cl KVNMYULPYGGEOT-UHFFFAOYSA-N 0.000 description 1
- NMZHSVIZYGWYRJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)C=C2.O=C(O)C(F)(F)F NMZHSVIZYGWYRJ-UHFFFAOYSA-N 0.000 description 1
- GAFIWNZYSWLMAZ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCC1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F GAFIWNZYSWLMAZ-UHFFFAOYSA-N 0.000 description 1
- MYIMMOUWCNWXNI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCO)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCO)N=C2.O=C(O)C(F)(F)F MYIMMOUWCNWXNI-UHFFFAOYSA-N 0.000 description 1
- SASQGAVQMHMKLM-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC)C(OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC)C(OC)=N2.[H]Cl SASQGAVQMHMKLM-UHFFFAOYSA-N 0.000 description 1
- OYLZLOAIMVHACO-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC)C(SCC(=O)OC)=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC)C(SCC(=O)OC)=N2.[H]Cl OYLZLOAIMVHACO-UHFFFAOYSA-N 0.000 description 1
- BGNXIOSCYDSNDE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC)N=C2.O=C(O)C(F)(F)F BGNXIOSCYDSNDE-UHFFFAOYSA-N 0.000 description 1
- GVAFRYFZCSHGQQ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC1=CC=CC=C1)C=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC1=CC=CC=C1)C=C2.O=C(O)C(F)(F)F GVAFRYFZCSHGQQ-UHFFFAOYSA-N 0.000 description 1
- IJUHKAZWHGPQTE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(CCOC1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F IJUHKAZWHGPQTE-UHFFFAOYSA-N 0.000 description 1
- OGYKMXYRNIKLJE-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(COCC1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(COCC1=CC=CC=C1)N=C2.O=C(O)C(F)(F)F OGYKMXYRNIKLJE-UHFFFAOYSA-N 0.000 description 1
- LQHXXIJGBCIFDI-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(COCC[Si](C)(C)C)C(Cl)=N2 Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N(COCC[Si](C)(C)C)C(Cl)=N2 LQHXXIJGBCIFDI-UHFFFAOYSA-N 0.000 description 1
- OUEGNHILOIGKRA-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N1CCCOC1=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N1CCCOC1=N2.[H]Cl OUEGNHILOIGKRA-UHFFFAOYSA-N 0.000 description 1
- AFOBCFONDSDJKD-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N1CCOC1=N2.[H]Cl Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)N1CCOC1=N2.[H]Cl AFOBCFONDSDJKD-UHFFFAOYSA-N 0.000 description 1
- MPVRJAYMDRHQFJ-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(C(=O)OC)=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(C(=O)OC)=C2.O=C(O)C(F)(F)F MPVRJAYMDRHQFJ-UHFFFAOYSA-N 0.000 description 1
- ZNBGIMZVAIBEKN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(Cl)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(Cl)=N2.O=C(O)C(F)(F)F ZNBGIMZVAIBEKN-UHFFFAOYSA-N 0.000 description 1
- CCZYXJGCHLOANF-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(OC1=CC=C(C(=O)O)C=C1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(OC1=CC=C(C(=O)O)C=C1)=N2.O=C(O)C(F)(F)F CCZYXJGCHLOANF-UHFFFAOYSA-N 0.000 description 1
- NZGYPHQSHFMMIN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(OC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(OC1=CC=CC=C1C(N)=O)=N2.O=C(O)C(F)(F)F NZGYPHQSHFMMIN-UHFFFAOYSA-N 0.000 description 1
- OSSOXEHKDYZMLB-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(SC(C)(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(SC(C)(C)C)=N2.O=C(O)C(F)(F)F OSSOXEHKDYZMLB-UHFFFAOYSA-N 0.000 description 1
- GHPZKIPETZBHPN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(SC(C)C)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(SC(C)C)=N2.O=C(O)C(F)(F)F GHPZKIPETZBHPN-UHFFFAOYSA-N 0.000 description 1
- XYAIHZXRAQQTHH-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(SC)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC(SC)=N2.O=C(O)C(F)(F)F XYAIHZXRAQQTHH-UHFFFAOYSA-N 0.000 description 1
- FGDUAEWVRVWZJN-UHFFFAOYSA-N CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N2CCNCC2)=NC2=C1C(=O)NC=C2.O=C(O)C(F)(F)F FGDUAEWVRVWZJN-UHFFFAOYSA-N 0.000 description 1
- PODMBAPQZOOHMV-NWDGAFQWSA-N CC#CCN1C(N[C@@H]2CCCC[C@@H]2N)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N[C@@H]2CCCC[C@@H]2N)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F PODMBAPQZOOHMV-NWDGAFQWSA-N 0.000 description 1
- PODMBAPQZOOHMV-VXGBXAGGSA-N CC#CCN1C(N[C@@H]2CCCC[C@H]2N)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CC#CCN1C(N[C@@H]2CCCC[C@H]2N)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F PODMBAPQZOOHMV-VXGBXAGGSA-N 0.000 description 1
- MJKVNQQJEZALNY-UHFFFAOYSA-N CC#CCN1C=NC2=C1C(=O)N(C)C(=O)N2 Chemical compound CC#CCN1C=NC2=C1C(=O)N(C)C(=O)N2 MJKVNQQJEZALNY-UHFFFAOYSA-N 0.000 description 1
- CPLWLMDNRLTZHK-UHFFFAOYSA-N CC#CCN1C=NC2=C1C(=O)NC(=O)N2C Chemical compound CC#CCN1C=NC2=C1C(=O)NC(=O)N2C CPLWLMDNRLTZHK-UHFFFAOYSA-N 0.000 description 1
- BBSOVPYZNMCXRQ-UHFFFAOYSA-N CC#CCN1C=NC2=CC=NC(Cl)=C21 Chemical compound CC#CCN1C=NC2=CC=NC(Cl)=C21 BBSOVPYZNMCXRQ-UHFFFAOYSA-N 0.000 description 1
- CIJAIIHOQXYIBY-UHFFFAOYSA-N CC#CCOC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CC#CCOC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F CIJAIIHOQXYIBY-UHFFFAOYSA-N 0.000 description 1
- PHXCGHLQHOJRLR-UHFFFAOYSA-N CC#CC[n]1c(N2CCNCC2)nc(C(/[O]=C(\C(F)(F)F)/O)=NN2CCOc3ccccc3)c1C2=O Chemical compound CC#CC[n]1c(N2CCNCC2)nc(C(/[O]=C(\C(F)(F)F)/O)=NN2CCOc3ccccc3)c1C2=O PHXCGHLQHOJRLR-UHFFFAOYSA-N 0.000 description 1
- JYPCCVMTOYQZGN-UHFFFAOYSA-N CC#CC[n]1c(N2CCNCC2)nc(C(c(cc2)ccc2/[O]=C(/C(F)(F)F)\O)=NN2Cc(cccc3)c3C#N)c1C2=O Chemical compound CC#CC[n]1c(N2CCNCC2)nc(C(c(cc2)ccc2/[O]=C(/C(F)(F)F)\O)=NN2Cc(cccc3)c3C#N)c1C2=O JYPCCVMTOYQZGN-UHFFFAOYSA-N 0.000 description 1
- IZQITCQFHSSUMX-UHFFFAOYSA-N CC#CC[n]1c(N2CCNCC2)nc(C=NN2Cc(cc3)ncc3C(OC)=O)c1C2=O Chemical compound CC#CC[n]1c(N2CCNCC2)nc(C=NN2Cc(cc3)ncc3C(OC)=O)c1C2=O IZQITCQFHSSUMX-UHFFFAOYSA-N 0.000 description 1
- MSPIKHNYGAJEEZ-UHFFFAOYSA-N CC(C)(C)C(=O)OCN1C(=O)C2=C(N=CN2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CC(C)(C)C(=O)OCN1C(=O)C2=C(N=CN2)N(COC(=O)C(C)(C)C)C1=O MSPIKHNYGAJEEZ-UHFFFAOYSA-N 0.000 description 1
- UDOLFIPHRQVVAY-UHFFFAOYSA-N CC(C)(C)C(=O)OCN1C(=O)C2=C(N=CN2C2=C(Cl)C=CC=C2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CC(C)(C)C(=O)OCN1C(=O)C2=C(N=CN2C2=C(Cl)C=CC=C2)N(COC(=O)C(C)(C)C)C1=O UDOLFIPHRQVVAY-UHFFFAOYSA-N 0.000 description 1
- OBMBLASADVXKLU-UHFFFAOYSA-N CC(C)(C)C(=O)OCN1C(=O)C2=C(N=CN2CC2=CC=CC=C2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CC(C)(C)C(=O)OCN1C(=O)C2=C(N=CN2CC2=CC=CC=C2)N(COC(=O)C(C)(C)C)C1=O OBMBLASADVXKLU-UHFFFAOYSA-N 0.000 description 1
- WTBNKROSXQAYHP-UHFFFAOYSA-N CC(C)(C)C(=O)OCN1C(=O)N(CCC2=CC=CC=C2)C(=O)C2=C1N=CN2CC1=CC=CC=C1 Chemical compound CC(C)(C)C(=O)OCN1C(=O)N(CCC2=CC=CC=C2)C(=O)C2=C1N=CN2CC1=CC=CC=C1 WTBNKROSXQAYHP-UHFFFAOYSA-N 0.000 description 1
- LRSDKIVOTHPPBI-UHFFFAOYSA-N CC(C)(C)C(=O)OCN1C(=O)NC(=O)C2=C1N=CN2CC1=CC=CC=C1 Chemical compound CC(C)(C)C(=O)OCN1C(=O)NC(=O)C2=C1N=CN2CC1=CC=CC=C1 LRSDKIVOTHPPBI-UHFFFAOYSA-N 0.000 description 1
- YOOGHVIFQSBNAV-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)N(COC(=O)C(C)(C)C)C(=O)N3)N2C2=C(Cl)C=CC=C2)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)N(COC(=O)C(C)(C)C)C(=O)N3)N2C2=C(Cl)C=CC=C2)CC1 YOOGHVIFQSBNAV-UHFFFAOYSA-N 0.000 description 1
- QYPYIIXPDFSULP-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)N(COC(=O)C(C)(C)C)C(=O)N3COC(=O)C(C)(C)C)N2C2=C(Cl)C=CC=C2)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)N(COC(=O)C(C)(C)C)C(=O)N3COC(=O)C(C)(C)C)N2C2=C(Cl)C=CC=C2)CC1 QYPYIIXPDFSULP-UHFFFAOYSA-N 0.000 description 1
- ANIHKRWBKRYJSP-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)N(COCC4=CC=CC=C4)N=C3)N2CC2=CC=CC=C2)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)N(COCC4=CC=CC=C4)N=C3)N2CC2=CC=CC=C2)CC1 ANIHKRWBKRYJSP-UHFFFAOYSA-N 0.000 description 1
- SMBCRGJDQAUIRZ-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)NC=N3)N2CC2=CC=CC=C2)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(=O)NC=N3)N2CC2=CC=CC=C2)CC1 SMBCRGJDQAUIRZ-UHFFFAOYSA-N 0.000 description 1
- YZLFPOJLNOJBCZ-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(Cl)NC(Cl)=N3)N2C2=C(Cl)C=CC=C2)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=C(C(Cl)NC(Cl)=N3)N2C2=C(Cl)C=CC=C2)CC1 YZLFPOJLNOJBCZ-UHFFFAOYSA-N 0.000 description 1
- VBIHDXXORWPUNV-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=C(N2)C(=O)N(COCC2=CC=CC=C2)N=C3)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=C(N2)C(=O)N(COCC2=CC=CC=C2)N=C3)CC1 VBIHDXXORWPUNV-UHFFFAOYSA-N 0.000 description 1
- PRIRAJBYJZFJCM-UHFFFAOYSA-N CC(C)(C)OC(=O)N1CCN(C2=NC3=CC=NC(Cl)=C3N2CC2=CC=CC=C2)CC1 Chemical compound CC(C)(C)OC(=O)N1CCN(C2=NC3=CC=NC(Cl)=C3N2CC2=CC=CC=C2)CC1 PRIRAJBYJZFJCM-UHFFFAOYSA-N 0.000 description 1
- SIONIIVXRCVHFL-UHFFFAOYSA-N CC(C)(C)OC(=O)NC1CCCN(C(=O)OCC2=CC=CC=C2)C1 Chemical compound CC(C)(C)OC(=O)NC1CCCN(C(=O)OCC2=CC=CC=C2)C1 SIONIIVXRCVHFL-UHFFFAOYSA-N 0.000 description 1
- HWTNZSIDJZOTGA-BJMVGYQFSA-N CC(C)/C1=C/CCNCCC1 Chemical compound CC(C)/C1=C/CCNCCC1 HWTNZSIDJZOTGA-BJMVGYQFSA-N 0.000 description 1
- RJSMNRDLMOOSOU-UHFFFAOYSA-N CC(C)=CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CC(C)=CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F RJSMNRDLMOOSOU-UHFFFAOYSA-N 0.000 description 1
- ROWCYOGNGZLTPL-UHFFFAOYSA-N CC(C)C1CCCNCCC1 Chemical compound CC(C)C1CCCNCCC1 ROWCYOGNGZLTPL-UHFFFAOYSA-N 0.000 description 1
- BBUYDKDSOGHLTK-LABLOBTQSA-N CC(C)N1CCC(N)CC1.CC(C)N1CCC(NC(=O)OC(C)(C)C)CC1.CC(C)N1CCCC(N)C1.CC(C)N1CCCC(NC(=O)OC(C)(C)C)C1.CC(C)N1CCCCC1.CC(C)N1CCC[C@@H](N)C1.CC(C)N1CCC[C@@H](NC(=O)OC(C)(C)C)C1.CC(C)N1CCC[C@H](N)C1.CC(C)N1CCC[C@H](NC(=O)OC(C)(C)C)C1 Chemical compound CC(C)N1CCC(N)CC1.CC(C)N1CCC(NC(=O)OC(C)(C)C)CC1.CC(C)N1CCCC(N)C1.CC(C)N1CCCC(NC(=O)OC(C)(C)C)C1.CC(C)N1CCCCC1.CC(C)N1CCC[C@@H](N)C1.CC(C)N1CCC[C@@H](NC(=O)OC(C)(C)C)C1.CC(C)N1CCC[C@H](N)C1.CC(C)N1CCC[C@H](NC(=O)OC(C)(C)C)C1 BBUYDKDSOGHLTK-LABLOBTQSA-N 0.000 description 1
- KXIXHISTUVHOCY-UHFFFAOYSA-N CC(C)N1CCCCC1 Chemical compound CC(C)N1CCCCC1 KXIXHISTUVHOCY-UHFFFAOYSA-N 0.000 description 1
- VIKSXCZOOFOILH-UHFFFAOYSA-N CC(C)N1CCCCCCC1.CC(C)N1CCCNCC1.CC(C)N1CCNCC1 Chemical compound CC(C)N1CCCCCCC1.CC(C)N1CCCNCC1.CC(C)N1CCNCC1 VIKSXCZOOFOILH-UHFFFAOYSA-N 0.000 description 1
- ZFSJFCNHPHANOM-UHFFFAOYSA-N CC(C)N1CCN(C(=O)OC(C)(C)C)CC1.CC(C)N1CCNCC1 Chemical compound CC(C)N1CCN(C(=O)OC(C)(C)C)CC1.CC(C)N1CCNCC1 ZFSJFCNHPHANOM-UHFFFAOYSA-N 0.000 description 1
- AZIBGKITOUHUNN-QUPXDVNDSA-N CC(C)NC1CCCCC1N.CC(C)N[C@H]1CCCC[C@@H]1N.CC(C)N[C@H]1CCCC[C@H]1N Chemical compound CC(C)NC1CCCCC1N.CC(C)N[C@H]1CCCC[C@@H]1N.CC(C)N[C@H]1CCCC[C@H]1N AZIBGKITOUHUNN-QUPXDVNDSA-N 0.000 description 1
- AVEHLSFEBCXAEY-UHFFFAOYSA-N CC.CC1=NC2=C(C(=O)NC(=O)N2C)N1C.CC1=NC2=C(C(Cl)=NC(Cl)=N2)N1C.CN1C(=O)NC(=O)C2=C1N=CN2.CN1C=NC2=C1C(=O)NC(=O)N2C.CN1CCN(C2=NC3=C(C(Cl)=NC(Cl)=N3)N2C)CC1.CN1CCNCC1 Chemical compound CC.CC1=NC2=C(C(=O)NC(=O)N2C)N1C.CC1=NC2=C(C(Cl)=NC(Cl)=N2)N1C.CN1C(=O)NC(=O)C2=C1N=CN2.CN1C=NC2=C1C(=O)NC(=O)N2C.CN1CCN(C2=NC3=C(C(Cl)=NC(Cl)=N3)N2C)CC1.CN1CCNCC1 AVEHLSFEBCXAEY-UHFFFAOYSA-N 0.000 description 1
- YHKLHISCNJNIMC-SNAWJCMRSA-N CC/C=C/C[n]1c(N2CCNCC2)nc(C=NN2C)c1C2=O Chemical compound CC/C=C/C[n]1c(N2CCNCC2)nc(C=NN2C)c1C2=O YHKLHISCNJNIMC-SNAWJCMRSA-N 0.000 description 1
- CIQUUMHWCAOHPE-UHFFFAOYSA-N CC=CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CC=CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F CIQUUMHWCAOHPE-UHFFFAOYSA-N 0.000 description 1
- YXJPOIKPPIPDBD-UHFFFAOYSA-N CCC(C)NC(CCCC1)C1N Chemical compound CCC(C)NC(CCCC1)C1N YXJPOIKPPIPDBD-UHFFFAOYSA-N 0.000 description 1
- YHKLHISCNJNIMC-UHFFFAOYSA-N CCC=CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F Chemical compound CCC=CCN1C(N2CCNCC2)=NC2=C1C(=O)N(C)N=C2.O=C(O)C(F)(F)F YHKLHISCNJNIMC-UHFFFAOYSA-N 0.000 description 1
- LDHTWVHTECIJHM-UHFFFAOYSA-N CCCCCCCCCCCCSC(N(C)C1=O)=Nc2c1[n](CC#CC)c(NCCN)n2 Chemical compound CCCCCCCCCCCCSC(N(C)C1=O)=Nc2c1[n](CC#CC)c(NCCN)n2 LDHTWVHTECIJHM-UHFFFAOYSA-N 0.000 description 1
- CGCWLDPHBGCXJG-SFBRDEECSA-N CCOC(=O)/C=C/C1=C(C#N)N(C)C(N2CCN(C)CC2)=N1.CN1C(N2CCNCC2)=NC2=C1C(=O)NC=C2.CN1CCN(C2=NC(/C=C/C(=O)N=[N+]=[N-])=C(C#N)N2C)CC1.CN1CCN(C2=NC(/C=C/C(=O)O)=C(C#N)N2C)CC1.CN1CCN(C2=NC(/C=C/NC(=O)OC(C)(C)C)=C(C#N)N2C)CC1.CN1CCN(C2=NC(/C=C/NC(=O)OC(C)(C)C)=C(C(N)=O)N2C)CC1.CN1CCN(C2=NC(CO)=C(C#N)N2C)CC1.[H]C(=O)C1=C(C#N)N(C)C(N2CCN(C)CC2)=N1 Chemical compound CCOC(=O)/C=C/C1=C(C#N)N(C)C(N2CCN(C)CC2)=N1.CN1C(N2CCNCC2)=NC2=C1C(=O)NC=C2.CN1CCN(C2=NC(/C=C/C(=O)N=[N+]=[N-])=C(C#N)N2C)CC1.CN1CCN(C2=NC(/C=C/C(=O)O)=C(C#N)N2C)CC1.CN1CCN(C2=NC(/C=C/NC(=O)OC(C)(C)C)=C(C#N)N2C)CC1.CN1CCN(C2=NC(/C=C/NC(=O)OC(C)(C)C)=C(C(N)=O)N2C)CC1.CN1CCN(C2=NC(CO)=C(C#N)N2C)CC1.[H]C(=O)C1=C(C#N)N(C)C(N2CCN(C)CC2)=N1 CGCWLDPHBGCXJG-SFBRDEECSA-N 0.000 description 1
- WVHCDIBFMNKZOQ-UHFFFAOYSA-N CCOC(=O)CN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CCOC(=O)CN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F WVHCDIBFMNKZOQ-UHFFFAOYSA-N 0.000 description 1
- ZADLWRRMXPNOAY-UHFFFAOYSA-N CCOC(=O)CN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CCOC(=O)CN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F ZADLWRRMXPNOAY-UHFFFAOYSA-N 0.000 description 1
- PEUBQAUZFIMQCU-UHFFFAOYSA-N CCOC(=O)COC1=NC2=C(C(=O)N1C)N(C1=C(Cl)C=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CCOC(=O)COC1=NC2=C(C(=O)N1C)N(C1=C(Cl)C=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F PEUBQAUZFIMQCU-UHFFFAOYSA-N 0.000 description 1
- RTXNDTNDOHQMTI-UHFFFAOYSA-N CN(C(=O)OC(C)(C)C)C1CCCNC1 Chemical compound CN(C(=O)OC(C)(C)C)C1CCCNC1 RTXNDTNDOHQMTI-UHFFFAOYSA-N 0.000 description 1
- KKUHLEUWNVZRED-UHFFFAOYSA-N CN(C)C1=NC2=C(C(=O)N3CCC3=C2)N1C Chemical compound CN(C)C1=NC2=C(C(=O)N3CCC3=C2)N1C KKUHLEUWNVZRED-UHFFFAOYSA-N 0.000 description 1
- AEAOBNAHXZUIQN-UHFFFAOYSA-N CN(C)C1=NN(C)C(=O)C2=C1N(CC1=CC=CC=C1)C(Cl)=N2 Chemical compound CN(C)C1=NN(C)C(=O)C2=C1N(CC1=CC=CC=C1)C(Cl)=N2 AEAOBNAHXZUIQN-UHFFFAOYSA-N 0.000 description 1
- AXHKVXMHTTYJGM-UHFFFAOYSA-N CN(C)C1=NN(C)C(=O)C2=C1N(CC1=CC=CC=C1)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 Chemical compound CN(C)C1=NN(C)C(=O)C2=C1N(CC1=CC=CC=C1)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 AXHKVXMHTTYJGM-UHFFFAOYSA-N 0.000 description 1
- FQEJVXNIBGFTBL-UHFFFAOYSA-N CN(C)C1=NN(C)C(=O)C2=C1N(CC1=CC=CC=C1)C=N2 Chemical compound CN(C)C1=NN(C)C(=O)C2=C1N(CC1=CC=CC=C1)C=N2 FQEJVXNIBGFTBL-UHFFFAOYSA-N 0.000 description 1
- JKBXWCBGYBOKCQ-UHFFFAOYSA-N CN(C)S(=O)(=O)N1C(Cl)=NC2=C1C=NN(COCC1=CC=CC=C1)C2=O Chemical compound CN(C)S(=O)(=O)N1C(Cl)=NC2=C1C=NN(COCC1=CC=CC=C1)C2=O JKBXWCBGYBOKCQ-UHFFFAOYSA-N 0.000 description 1
- QJFODBVFHIFSHY-UHFFFAOYSA-N CN(C)S(=O)(=O)N1C=NC2=C1C=NN(COCC1=CC=CC=C1)C2=O Chemical compound CN(C)S(=O)(=O)N1C=NC2=C1C=NN(COCC1=CC=CC=C1)C2=O QJFODBVFHIFSHY-UHFFFAOYSA-N 0.000 description 1
- JEVQOXPRVAIKLL-UHFFFAOYSA-N CN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2C1=C(Cl)C=CC=C1 Chemical compound CN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2C1=C(Cl)C=CC=C1 JEVQOXPRVAIKLL-UHFFFAOYSA-N 0.000 description 1
- ZZRBNBAENLHCQP-UHFFFAOYSA-N CN1C(=O)C2=C(N=C1OCC(=O)O)N=C(N1CCNCC1)N2C1=C(Cl)C=CC=C1.O=C(O)C(F)(F)F Chemical compound CN1C(=O)C2=C(N=C1OCC(=O)O)N=C(N1CCNCC1)N2C1=C(Cl)C=CC=C1.O=C(O)C(F)(F)F ZZRBNBAENLHCQP-UHFFFAOYSA-N 0.000 description 1
- USQCVQKTAQCGHR-UHFFFAOYSA-N CN1C(=O)C2=C(N=CN2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CN1C(=O)C2=C(N=CN2)N(COC(=O)C(C)(C)C)C1=O USQCVQKTAQCGHR-UHFFFAOYSA-N 0.000 description 1
- UICVVNQQOOFSFC-UHFFFAOYSA-N CN1C(=O)C2=C(N=CN2C2=C(Cl)C=CC=C2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CN1C(=O)C2=C(N=CN2C2=C(Cl)C=CC=C2)N(COC(=O)C(C)(C)C)C1=O UICVVNQQOOFSFC-UHFFFAOYSA-N 0.000 description 1
- LDYBCIIYBRKOEL-UHFFFAOYSA-N CN1C(=O)C2=C(N=CN2CC2=CC=CC=C2)N(COC(=O)C(C)(C)C)C1=O Chemical compound CN1C(=O)C2=C(N=CN2CC2=CC=CC=C2)N(COC(=O)C(C)(C)C)C1=O LDYBCIIYBRKOEL-UHFFFAOYSA-N 0.000 description 1
- GGHJQESFLNUKPG-UHFFFAOYSA-N CN1C(=O)NC2=C(C1=O)N(C1=C(Cl)C=CC=C1)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 Chemical compound CN1C(=O)NC2=C(C1=O)N(C1=C(Cl)C=CC=C1)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 GGHJQESFLNUKPG-UHFFFAOYSA-N 0.000 description 1
- BFPJGQYJIYVSTA-UHFFFAOYSA-N CN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F BFPJGQYJIYVSTA-UHFFFAOYSA-N 0.000 description 1
- GNYLSGZJGPWITD-UHFFFAOYSA-N CN1N=C(Cl)C2=C(N=CN2CC2=CC=CC=C2)C1=O Chemical compound CN1N=C(Cl)C2=C(N=CN2CC2=CC=CC=C2)C1=O GNYLSGZJGPWITD-UHFFFAOYSA-N 0.000 description 1
- QMLRXOYEOJRKKV-UHFFFAOYSA-N CN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F QMLRXOYEOJRKKV-UHFFFAOYSA-N 0.000 description 1
- XHQNHEZZJFHUSJ-UHFFFAOYSA-N CN1N=CC2=C(C1=O)N(CC1CC1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound CN1N=CC2=C(C1=O)N(CC1CC1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F XHQNHEZZJFHUSJ-UHFFFAOYSA-N 0.000 description 1
- JSTSAENIJBLKIN-UHFFFAOYSA-N CN1N=CC2=C(N=C(Cl)N2C(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C1=O Chemical compound CN1N=CC2=C(N=C(Cl)N2C(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C1=O JSTSAENIJBLKIN-UHFFFAOYSA-N 0.000 description 1
- OCVFAPLOXXJMHY-UHFFFAOYSA-N CN1N=CC2=C(N=CN2C(=O)OC(C)(C)C)C1=O Chemical compound CN1N=CC2=C(N=CN2C(=O)OC(C)(C)C)C1=O OCVFAPLOXXJMHY-UHFFFAOYSA-N 0.000 description 1
- PNXODGIDMSYKSD-UHFFFAOYSA-N CN1N=CC2=C(N=CN2C(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C1=O Chemical compound CN1N=CC2=C(N=CN2C(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C1=O PNXODGIDMSYKSD-UHFFFAOYSA-N 0.000 description 1
- IKPZSRJECFOXPV-UHFFFAOYSA-N CN1N=CC2=C(NC(C3CCNCC3)=N2)C1=O.O=C(O)C(F)(F)F Chemical compound CN1N=CC2=C(NC(C3CCNCC3)=N2)C1=O.O=C(O)C(F)(F)F IKPZSRJECFOXPV-UHFFFAOYSA-N 0.000 description 1
- ZYQIHSPUQORWGM-UHFFFAOYSA-N COC1=CC(C(=O)CN2N=CC3=C(C2=O)N(CC2=CC=CC=C2)C(N2CCNCC2)=N3)=CC=C1.O=C(O)C(F)(F)F Chemical compound COC1=CC(C(=O)CN2N=CC3=C(C2=O)N(CC2=CC=CC=C2)C(N2CCNCC2)=N3)=CC=C1.O=C(O)C(F)(F)F ZYQIHSPUQORWGM-UHFFFAOYSA-N 0.000 description 1
- NXCHUHHKHNFEED-UHFFFAOYSA-N COCCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound COCCN1C=NC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F NXCHUHHKHNFEED-UHFFFAOYSA-N 0.000 description 1
- HWAJNNZUCNYDNI-UHFFFAOYSA-N COCCN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound COCCN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F HWAJNNZUCNYDNI-UHFFFAOYSA-N 0.000 description 1
- FEUISMYEFPANSS-NKWVEPMBSA-N C[C@@H](CCCC1)[C@@H]1N Chemical compound C[C@@H](CCCC1)[C@@H]1N FEUISMYEFPANSS-NKWVEPMBSA-N 0.000 description 1
- XKJRANQIIRPARX-UHFFFAOYSA-N ClC1=NC2=CC=NC(Cl)=C2N1CC1=CC=CC=C1 Chemical compound ClC1=NC2=CC=NC(Cl)=C2N1CC1=CC=CC=C1 XKJRANQIIRPARX-UHFFFAOYSA-N 0.000 description 1
- SPDPIRYZWOTOGB-UHFFFAOYSA-N N#CC1=C(CN2N=CC3=C(C2=O)N(CC2=CC=CC=C2)C(N2CCNCC2)=N3)C=CC=C1.O=C(O)C(F)(F)F Chemical compound N#CC1=C(CN2N=CC3=C(C2=O)N(CC2=CC=CC=C2)C(N2CCNCC2)=N3)C=CC=C1.O=C(O)C(F)(F)F SPDPIRYZWOTOGB-UHFFFAOYSA-N 0.000 description 1
- DAVUAPTTYKRMKB-UHFFFAOYSA-N N#CCN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F Chemical compound N#CCN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2.O=C(O)C(F)(F)F DAVUAPTTYKRMKB-UHFFFAOYSA-N 0.000 description 1
- VUFZSDOCWFOKRC-UHFFFAOYSA-N O=C(CN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2)C1=CC=CC=C1.O=C(O)C(F)(F)F Chemical compound O=C(CN1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2)C1=CC=CC=C1.O=C(O)C(F)(F)F VUFZSDOCWFOKRC-UHFFFAOYSA-N 0.000 description 1
- KHFCHIYWFSRCLG-UHFFFAOYSA-N O=C(O)C(F)(F)F.O=C1C2=C(C=NN1CCC1=CC=CC=C1)N=C(N1CCNCC1)N2CC1=CC=CC=C1 Chemical compound O=C(O)C(F)(F)F.O=C1C2=C(C=NN1CCC1=CC=CC=C1)N=C(N1CCNCC1)N2CC1=CC=CC=C1 KHFCHIYWFSRCLG-UHFFFAOYSA-N 0.000 description 1
- JLUPNTZXEHAAFB-UHFFFAOYSA-N O=C(O)C(F)(F)F.O=C1C2=C(C=NN1CCO)N=C(N1CCNCC1)N2CC1=CC=CC=C1 Chemical compound O=C(O)C(F)(F)F.O=C1C2=C(C=NN1CCO)N=C(N1CCNCC1)N2CC1=CC=CC=C1 JLUPNTZXEHAAFB-UHFFFAOYSA-N 0.000 description 1
- KWUVXDXCBDWBCS-UHFFFAOYSA-N O=C(O)C(F)(F)F.O=C1C2=C(C=NN1CCOC1=CC=CC=C1)N=C(N1CCNCC1)N2CC1=CC=CC=C1 Chemical compound O=C(O)C(F)(F)F.O=C1C2=C(C=NN1CCOC1=CC=CC=C1)N=C(N1CCNCC1)N2CC1=CC=CC=C1 KWUVXDXCBDWBCS-UHFFFAOYSA-N 0.000 description 1
- CGTWOBUUJXHBEJ-UHFFFAOYSA-N O=C(O)C(F)(F)F.O=C1NC(OC2CCC2)=NC2=C1N(C1=C(Cl)C=CC=C1)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.O=C1NC(OC2CCC2)=NC2=C1N(C1=C(Cl)C=CC=C1)C(N1CCNCC1)=N2 CGTWOBUUJXHBEJ-UHFFFAOYSA-N 0.000 description 1
- DZCZRQBEKGCQIQ-UHFFFAOYSA-N O=C(O)C(F)(F)F.O=C1NC=CC2=C1N(CC1=CC=CC=C1)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.O=C1NC=CC2=C1N(CC1=CC=CC=C1)C(N1CCNCC1)=N2 DZCZRQBEKGCQIQ-UHFFFAOYSA-N 0.000 description 1
- PVWABLAUXZVJOX-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC(CN2C(=O)C3=C(N=C2OC2=CC=CC=C2C(N)=O)N=C(N2CCNCC2)N3CC#CC)=CC=C1 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC(CN2C(=O)C3=C(N=C2OC2=CC=CC=C2C(N)=O)N=C(N2CCNCC2)N3CC#CC)=CC=C1 PVWABLAUXZVJOX-UHFFFAOYSA-N 0.000 description 1
- OCGBMLMVMYFOEI-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC(CN2C(=O)C3=C(N=C2[N+]#[C-])N=C(N2CCNCC2)N3CC#CC)=CC=C1 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC(CN2C(=O)C3=C(N=C2[N+]#[C-])N=C(N2CCNCC2)N3CC#CC)=CC=C1 OCGBMLMVMYFOEI-UHFFFAOYSA-N 0.000 description 1
- KUYDROQWJFCFNI-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC(OC2=NC3=C(C(=O)N2C)N(CC#CC)C(N2CCNCC2)=N3)=CC=C1 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC(OC2=NC3=C(C(=O)N2C)N(CC#CC)C(N2CCNCC2)=N3)=CC=C1 KUYDROQWJFCFNI-UHFFFAOYSA-N 0.000 description 1
- WCBMATKLBIEXGN-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=C(OC2=NC3=C(C(=O)N2C)N(CC#CC)C(N2CCNCC2)=N3)C(OC)=C1 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=C(OC2=NC3=C(C(=O)N2C)N(CC#CC)C(N2CCNCC2)=N3)C(OC)=C1 WCBMATKLBIEXGN-UHFFFAOYSA-N 0.000 description 1
- IWDQDECNJMLRTO-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=C(OC2=NC3=C(C(=O)N2C)N(CC#CC)C(N2CCNCC2)=N3)C=C1 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=C(OC2=NC3=C(C(=O)N2C)N(CC#CC)C(N2CCNCC2)=N3)C=C1 IWDQDECNJMLRTO-UHFFFAOYSA-N 0.000 description 1
- SAJRQJNPBFCGLY-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=C(C(=O)O)C=C1)N=C(N1CCNCC1)N2CC#CC Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=C(C(=O)O)C=C1)N=C(N1CCNCC1)N2CC#CC SAJRQJNPBFCGLY-UHFFFAOYSA-N 0.000 description 1
- VGLOHDQBHCCMBU-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=C(S(N)(=O)=O)C=C1)N=C(N1CCNCC1)N2CC#CC Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=C(S(N)(=O)=O)C=C1)N=C(N1CCNCC1)N2CC#CC VGLOHDQBHCCMBU-UHFFFAOYSA-N 0.000 description 1
- RDTVWDSTLILDBZ-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=CC=C1C#N)N=C(N1CCNCC1)N2CC#CC Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=CC=C1C#N)N=C(N1CCNCC1)N2CC#CC RDTVWDSTLILDBZ-UHFFFAOYSA-N 0.000 description 1
- WVRVMACLYJRRBJ-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=CC=C1C(N)=O)N=C(N1CCNCC1)N2CC#CC Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=CC=C1C(N)=O)N=C(N1CCNCC1)N2CC#CC WVRVMACLYJRRBJ-UHFFFAOYSA-N 0.000 description 1
- PEOFOIGCFBHBTI-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=CN=C1C(N)=O)N=C(N1CCNCC1)N2CC#CC Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=CC=CC=C1CN1C(=O)C2=C(N=C1OC1=CC=CN=C1C(N)=O)N=C(N1CCNCC1)N2CC#CC PEOFOIGCFBHBTI-UHFFFAOYSA-N 0.000 description 1
- SUJKDJMCSIHVON-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=NC2=C(C(=O)N1)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=NC2=C(C(=O)N1)N(CC#CC)C(N1CCNCC1)=N2 SUJKDJMCSIHVON-UHFFFAOYSA-N 0.000 description 1
- IDANGDXHLSWRTC-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCCC(N)C1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCCC(N)C1)=N2 IDANGDXHLSWRTC-UHFFFAOYSA-N 0.000 description 1
- VXIXPIHWRSZMOI-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]C1=NC2=C(C(=O)N1CC1=CC=C(C#N)C=C1)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]C1=NC2=C(C(=O)N1CC1=CC=C(C#N)C=C1)N(CC#CC)C(N1CCNCC1)=N2 VXIXPIHWRSZMOI-UHFFFAOYSA-N 0.000 description 1
- JXMFJDJYGMVGPW-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]CC1(C[N+]#[C-])NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]CC1(C[N+]#[C-])NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 JXMFJDJYGMVGPW-UHFFFAOYSA-N 0.000 description 1
- VUXMJJCLEAYVBT-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]CC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]CC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 VUXMJJCLEAYVBT-UHFFFAOYSA-N 0.000 description 1
- DYCAKZXVABAJKV-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]CN(C)C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]CN(C)C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 DYCAKZXVABAJKV-UHFFFAOYSA-N 0.000 description 1
- LYLQZNGGTHLKCI-UHFFFAOYSA-N O=C(O)C(F)(F)F.[C-]#[N+]COC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[C-]#[N+]COC1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCNCC1)=N2 LYLQZNGGTHLKCI-UHFFFAOYSA-N 0.000 description 1
- BKVALOSDPLKKRR-UHFFFAOYSA-N O=C(O)C(F)(F)F.[H]N([H])C1CCCN(C2=NC3=C(C(=O)N(C)N=C3)N2CC#CC)C1 Chemical compound O=C(O)C(F)(F)F.[H]N([H])C1CCCN(C2=NC3=C(C(=O)N(C)N=C3)N2CC#CC)C1 BKVALOSDPLKKRR-UHFFFAOYSA-N 0.000 description 1
- YSCWNVOYSMCWCR-UHFFFAOYSA-N O=C(O)C(F)(F)F.[H]N([H])C1CCCN(C2=NC3=C(C(=O)N(C)N=C3)N2CC=C(C)C)C1 Chemical compound O=C(O)C(F)(F)F.[H]N([H])C1CCCN(C2=NC3=C(C(=O)N(C)N=C3)N2CC=C(C)C)C1 YSCWNVOYSMCWCR-UHFFFAOYSA-N 0.000 description 1
- SFHPADNJJMQDEG-UHFFFAOYSA-N O=C(O)C(F)(F)F.[H]N1CCN(C2=NC3=C(C(=O)NN=C3)N2CC#CC)CC1 Chemical compound O=C(O)C(F)(F)F.[H]N1CCN(C2=NC3=C(C(=O)NN=C3)N2CC#CC)CC1 SFHPADNJJMQDEG-UHFFFAOYSA-N 0.000 description 1
- JRURWXHOYQFOMB-UHFFFAOYSA-N O=C(O)C(F)(F)F.[H]N1N=C(C2=CC=CC=C2)C2=C(C1=O)N(CC#CC)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[H]N1N=C(C2=CC=CC=C2)C2=C(C1=O)N(CC#CC)C(N1CCNCC1)=N2 JRURWXHOYQFOMB-UHFFFAOYSA-N 0.000 description 1
- PLFLIGISKNBVFB-UHFFFAOYSA-N O=C(O)C(F)(F)F.[H]N1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2 Chemical compound O=C(O)C(F)(F)F.[H]N1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCNCC1)=N2 PLFLIGISKNBVFB-UHFFFAOYSA-N 0.000 description 1
- GHZWUMMLWJBAAX-UHFFFAOYSA-N O=C1C=CC=CN1.O=C1CCCC1.O=C1CCCCC1 Chemical compound O=C1C=CC=CN1.O=C1CCCC1.O=C1CCCCC1 GHZWUMMLWJBAAX-UHFFFAOYSA-N 0.000 description 1
- QOYGLSWWXXBIGG-UHFFFAOYSA-N O=C1NC=NC2=C1N(CC1=CC=CC=C1)C=N2 Chemical compound O=C1NC=NC2=C1N(CC1=CC=CC=C1)C=N2 QOYGLSWWXXBIGG-UHFFFAOYSA-N 0.000 description 1
- XUUKKXZVOVGFMR-UHFFFAOYSA-N [C-]#[N+]C1=CC(CN2C(=O)C3=C(N=C2Cl)N=C(N2CCN(C(=O)OC(C)(C)C)CC2)N3CC#CC)=CC=C1 Chemical compound [C-]#[N+]C1=CC(CN2C(=O)C3=C(N=C2Cl)N=C(N2CCN(C(=O)OC(C)(C)C)CC2)N3CC#CC)=CC=C1 XUUKKXZVOVGFMR-UHFFFAOYSA-N 0.000 description 1
- IWRSKOVDFQOTKO-UHFFFAOYSA-N [C-]#[N+]C1=CC=C(CN2C(=O)C3=C(N=C2Cl)N=C(N2CCCC(N)C2)N3CC#CC)C=C1.[H]Cl Chemical compound [C-]#[N+]C1=CC=C(CN2C(=O)C3=C(N=C2Cl)N=C(N2CCCC(N)C2)N3CC#CC)C=C1.[H]Cl IWRSKOVDFQOTKO-UHFFFAOYSA-N 0.000 description 1
- ZNXHFTXWSMCIKZ-UHFFFAOYSA-N [C-]#[N+]C1=CC=C(CN2C(=O)C3=C(N=C2Cl)N=C(N2CCCC(NC(=O)OC(C)(C)C)C2)N3CC#CC)C=C1 Chemical compound [C-]#[N+]C1=CC=C(CN2C(=O)C3=C(N=C2Cl)N=C(N2CCCC(NC(=O)OC(C)(C)C)C2)N3CC#CC)C=C1 ZNXHFTXWSMCIKZ-UHFFFAOYSA-N 0.000 description 1
- PSWUADSPTVJXCI-UHFFFAOYSA-N [C-]#[N+]C1=CC=C(CN2C(=O)C3=C(N=C2OC)N=C(N2CCCC(N)C2)N3CC#CC)C=C1.[H]Cl Chemical compound [C-]#[N+]C1=CC=C(CN2C(=O)C3=C(N=C2OC)N=C(N2CCCC(N)C2)N3CC#CC)C=C1.[H]Cl PSWUADSPTVJXCI-UHFFFAOYSA-N 0.000 description 1
- LZBWXHJJZKWQQR-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCC(N)C1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCC(N)C1)=N2.[H]Cl LZBWXHJJZKWQQR-UHFFFAOYSA-N 0.000 description 1
- HEEBPIWBXLGPIG-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCCC(NC)C1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1C)N(CC#CC)C(N1CCCC(NC)C1)=N2.[H]Cl HEEBPIWBXLGPIG-UHFFFAOYSA-N 0.000 description 1
- RETFYAZFVYATOQ-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CC#CC)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CC#CC)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl RETFYAZFVYATOQ-UHFFFAOYSA-N 0.000 description 1
- HCPPQVLXNIIISB-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CC1=C(C#N)C=CC=C1)N(CC#CC)C(N1CCCC(N)C1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CC1=C(C#N)C=CC=C1)N(CC#CC)C(N1CCCC(N)C1)=N2.[H]Cl HCPPQVLXNIIISB-UHFFFAOYSA-N 0.000 description 1
- VTNOZUOHKASHBH-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CC1=C(C#N)C=CC=C1)N(CC#CC)C(N1CCCC(NC(=O)OC(C)(C)C)C1)=N2 Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CC1=C(C#N)C=CC=C1)N(CC#CC)C(N1CCCC(NC(=O)OC(C)(C)C)C1)=N2 VTNOZUOHKASHBH-UHFFFAOYSA-N 0.000 description 1
- QICDETFXMPVTNY-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CC1=CC=CC=C1C#N)N(CC#CC)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CC1=CC=CC=C1C#N)N(CC#CC)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 QICDETFXMPVTNY-UHFFFAOYSA-N 0.000 description 1
- YSTSQWOLRWWURD-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CC1=CC=CC=C1C#N)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CC1=CC=CC=C1C#N)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl YSTSQWOLRWWURD-UHFFFAOYSA-N 0.000 description 1
- HPNLIDYGFGABGG-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CC=C)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CC=C)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl HPNLIDYGFGABGG-UHFFFAOYSA-N 0.000 description 1
- YZKBGPFMIXIXJU-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CCC1=CC=CC=C1)N(CC#CC)C(N1CCCC(N)C1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CCC1=CC=CC=C1)N(CC#CC)C(N1CCCC(N)C1)=N2.[H]Cl YZKBGPFMIXIXJU-UHFFFAOYSA-N 0.000 description 1
- VFYLEEQZBSFUBK-UHFFFAOYSA-N [C-]#[N+]C1=NC2=C(C(=O)N1CCOC)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl Chemical compound [C-]#[N+]C1=NC2=C(C(=O)N1CCOC)N(CC#CC)C(N1CCNCC1)=N2.[H]Cl VFYLEEQZBSFUBK-UHFFFAOYSA-N 0.000 description 1
- KLRQLWHVNNEYCS-UHFFFAOYSA-N [C-]#[N+]CN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2CC#CC Chemical compound [C-]#[N+]CN1C(=O)C2=C(N=C1Cl)N=C(N1CCN(C(=O)OC(C)(C)C)CC1)N2CC#CC KLRQLWHVNNEYCS-UHFFFAOYSA-N 0.000 description 1
- GHIBQWWVJZHBMW-UHFFFAOYSA-N [C-]#[N+]CN1C(=O)C2=C(N=C1SCC(=O)OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl Chemical compound [C-]#[N+]CN1C(=O)C2=C(N=C1SCC(=O)OC)N=C(N1CCNCC1)N2CC#CC.[H]Cl GHIBQWWVJZHBMW-UHFFFAOYSA-N 0.000 description 1
- AMWYRBBENXEKDD-UHFFFAOYSA-N [H]C(=O)C1=C(C#N)N(CC#CC)C(N2CCN(C(=O)OC(C)(C)C)CC2)=N1 Chemical compound [H]C(=O)C1=C(C#N)N(CC#CC)C(N2CCN(C(=O)OC(C)(C)C)CC2)=N1 AMWYRBBENXEKDD-UHFFFAOYSA-N 0.000 description 1
- HGOWXQZCPLWSAF-UHFFFAOYSA-N [H]C(=O)C1=C(C(=O)OCC)N(CC#CC)C(N2CCN(C(=O)OC(C)(C)C)CC2)=N1 Chemical compound [H]C(=O)C1=C(C(=O)OCC)N(CC#CC)C(N2CCN(C(=O)OC(C)(C)C)CC2)=N1 HGOWXQZCPLWSAF-UHFFFAOYSA-N 0.000 description 1
- YMQPZFYLUMLMAE-UHFFFAOYSA-N [H]C(=O)C1=C(C(=O)SC)N(CC#CC)C(N2CCN(C(=O)OC(C)(C)C)CC2)=N1 Chemical compound [H]C(=O)C1=C(C(=O)SC)N(CC#CC)C(N2CCN(C(=O)OC(C)(C)C)CC2)=N1 YMQPZFYLUMLMAE-UHFFFAOYSA-N 0.000 description 1
- URVMEEPQNQUOCK-UHFFFAOYSA-N [H]N(C(=O)OC(C)(C)C)C1CCCN(C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C1 Chemical compound [H]N(C(=O)OC(C)(C)C)C1CCCN(C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C1 URVMEEPQNQUOCK-UHFFFAOYSA-N 0.000 description 1
- IHLOUIXORUUEGY-UHFFFAOYSA-N [H]N1C(=O)N(CC2=CC=CC=C2)C2=C(Cl)N=CC=C21 Chemical compound [H]N1C(=O)N(CC2=CC=CC=C2)C2=C(Cl)N=CC=C21 IHLOUIXORUUEGY-UHFFFAOYSA-N 0.000 description 1
- XILNCAQXCFWOHS-UHFFFAOYSA-N [H]N1C(=O)N(CC=C)C2=CC=NC(Cl)=C21 Chemical compound [H]N1C(=O)N(CC=C)C2=CC=NC(Cl)=C21 XILNCAQXCFWOHS-UHFFFAOYSA-N 0.000 description 1
- BXLWXNPLQBGMAD-UHFFFAOYSA-N [H]N1C(C2=CC=NC=C2)=NC2=C1C=NN(C)C2=O Chemical compound [H]N1C(C2=CC=NC=C2)=NC2=C1C=NN(C)C2=O BXLWXNPLQBGMAD-UHFFFAOYSA-N 0.000 description 1
- WICQTTXIGYKJOQ-UHFFFAOYSA-N [H]N1C(Cl)=NC2=C1C=NN(C)C2=O Chemical compound [H]N1C(Cl)=NC2=C1C=NN(C)C2=O WICQTTXIGYKJOQ-UHFFFAOYSA-N 0.000 description 1
- QSCWNSBXSQPHKV-UHFFFAOYSA-N [H]N1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2 Chemical compound [H]N1C(N2CCN(C(=O)OC(C)(C)C)CC2)=NC2=C1C(=O)N(C)N=C2 QSCWNSBXSQPHKV-UHFFFAOYSA-N 0.000 description 1
- NCMMPXJACHUSFN-UHFFFAOYSA-N [H]N1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 Chemical compound [H]N1N=CC2=C(C1=O)N(CC1=CC=CC=C1)C(N1CCN(C(=O)OC(C)(C)C)CC1)=N2 NCMMPXJACHUSFN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/212,407 US20060063787A1 (en) | 2002-06-06 | 2005-08-26 | Condensed imidazole derivatives |
US12/199,982 US7772226B2 (en) | 2002-06-06 | 2008-08-28 | Condensed imidazole derivatives |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002166069 | 2002-06-06 | ||
JP2002-166069 | 2002-06-06 | ||
JP2002-209373 | 2002-07-18 | ||
JP2002209373 | 2002-07-18 | ||
JP2002-307750 | 2002-10-23 | ||
JP2002307750 | 2002-10-23 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/212,407 Continuation US20060063787A1 (en) | 2002-06-06 | 2005-08-26 | Condensed imidazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040116328A1 true US20040116328A1 (en) | 2004-06-17 |
Family
ID=29740540
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/516,971 Abandoned US20060100199A1 (en) | 2002-06-06 | 2003-06-03 | Novel condensed imidazole derivatives |
US10/457,002 Abandoned US20040116328A1 (en) | 2002-06-06 | 2003-06-06 | Condensed imidazole derivatives |
US11/212,407 Abandoned US20060063787A1 (en) | 2002-06-06 | 2005-08-26 | Condensed imidazole derivatives |
US12/199,982 Expired - Fee Related US7772226B2 (en) | 2002-06-06 | 2008-08-28 | Condensed imidazole derivatives |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/516,971 Abandoned US20060100199A1 (en) | 2002-06-06 | 2003-06-03 | Novel condensed imidazole derivatives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/212,407 Abandoned US20060063787A1 (en) | 2002-06-06 | 2005-08-26 | Condensed imidazole derivatives |
US12/199,982 Expired - Fee Related US7772226B2 (en) | 2002-06-06 | 2008-08-28 | Condensed imidazole derivatives |
Country Status (19)
Cited By (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040034014A1 (en) * | 2000-07-04 | 2004-02-19 | Kanstrup Anders Bendtz | Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
US20040082570A1 (en) * | 2002-02-25 | 2004-04-29 | Eisai Co., Ltd. | Xanthine derivative and DPPIV inhibitor |
US20040097510A1 (en) * | 2002-08-21 | 2004-05-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20040122228A1 (en) * | 2002-08-22 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040138215A1 (en) * | 2002-11-21 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040138214A1 (en) * | 2002-11-08 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040166125A1 (en) * | 2002-08-22 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, their preparation and their use in pharmaceutical compositions |
US20040242566A1 (en) * | 2003-03-25 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
WO2004108730A1 (en) * | 2003-06-05 | 2004-12-16 | Fujisawa Pharmaceutical Co., Ltd. | 1h-imidazo`4,5-d!pyridazines as dpp-iv inhibitors for the treatment of niddm |
WO2004111051A1 (de) * | 2003-06-18 | 2004-12-23 | Boehringer Ingelheim International Gmbh | Imidazopyridazinon- und imidazopyridonderivate, deren herstellung und deren verwendung als arzneimittel |
US20050020574A1 (en) * | 2002-12-03 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh Co. Kg | New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions |
US20050070706A1 (en) * | 2003-08-13 | 2005-03-31 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
WO2005058901A1 (de) * | 2003-12-17 | 2005-06-30 | Boehringer Ingelheim International Gmbh | Neue 2-(piperazin-1-yl)- und 2-([1,4]diazepan-1-yl)- imidazo[4,5-d]pyridazin-4-one, deren herstellung und deren verwendung als arzneimittel zur bekämpfung von diabetes mellitus |
US20050143377A1 (en) * | 2003-12-23 | 2005-06-30 | Boehringer Ingelheim International Gmbh | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
WO2005061505A1 (en) * | 2003-12-16 | 2005-07-07 | Pfizer Products Inc. | Bicyclic imidazolyl pyrimidin-4-one cannabinoid receptor ligands and uses thereof |
US20050171093A1 (en) * | 2003-12-17 | 2005-08-04 | Boehringer Ingelheim International Gmbh | New piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutial compositions |
US20050187227A1 (en) * | 2004-02-23 | 2005-08-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition |
US20050203095A1 (en) * | 2004-03-13 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
US20050234108A1 (en) * | 2004-02-18 | 2005-10-20 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
US20050261352A1 (en) * | 2004-05-10 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
US20060004074A1 (en) * | 2004-06-24 | 2006-01-05 | Boehringer Ingelheim International Gmbh | New imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
US20060058323A1 (en) * | 2004-09-11 | 2006-03-16 | Boehringer Ingelheim International Gmbh | New 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20060063787A1 (en) * | 2002-06-06 | 2006-03-23 | Eisai Co., Ltd. | Condensed imidazole derivatives |
US20060079541A1 (en) * | 2004-09-14 | 2006-04-13 | Boehringer Ingelheim International Gmbh | 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20060094722A1 (en) * | 2002-09-26 | 2006-05-04 | Eisai Co., Ltd. | Combination drug |
US20060111362A1 (en) * | 2002-12-04 | 2006-05-25 | Eisai Co., Ltd. | 1,3-Dihydroimidazole ring compound |
US20060142310A1 (en) * | 2004-11-05 | 2006-06-29 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines |
US20060154866A1 (en) * | 2005-01-10 | 2006-07-13 | Zhi-Liang Chu | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US20060247226A1 (en) * | 2001-02-24 | 2006-11-02 | Frank Himmelsbach | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20070027168A1 (en) * | 2005-07-30 | 2007-02-01 | Waldemar Pfrengle | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
US7179809B2 (en) | 2004-04-10 | 2007-02-20 | Boehringer Ingelheim International Gmbh | 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
US20070098781A1 (en) * | 2005-08-11 | 2007-05-03 | Loeffler Bernd M | Modified release compositions for DPP-IV inhibitors |
US20070219178A1 (en) * | 2003-12-04 | 2007-09-20 | Eisai Co., Ltd. | Preventive or therapeutic agents for multiple sclerosis |
US20070259900A1 (en) * | 2006-05-04 | 2007-11-08 | Peter Sieger | Polymorphs |
US20070281940A1 (en) * | 2006-05-04 | 2007-12-06 | Klaus Dugi | Uses of dpp-iv inhibitors |
US20080107731A1 (en) * | 2006-05-04 | 2008-05-08 | Anja Kohlrausch | Dpp iv inhibitor formulations |
US20080318922A1 (en) * | 2004-12-24 | 2008-12-25 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic Pyrrole Derivatives |
WO2009024542A2 (en) * | 2007-08-17 | 2009-02-26 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
US7550455B2 (en) | 2003-11-27 | 2009-06-23 | Boehringer Ingelheim International Gmbh | 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
US7566707B2 (en) | 2003-06-18 | 2009-07-28 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
WO2009111501A1 (en) * | 2008-03-04 | 2009-09-11 | Smithkline Beecham Corporation | Derivatives of imidazo [4, 5-d] pyridazine and their use as anti-viral compounds |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20100190750A1 (en) * | 2006-04-11 | 2010-07-29 | Arena Pharmaceuticals, Inc. | GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto |
US20100203577A1 (en) * | 2006-04-11 | 2010-08-12 | Arena Pharmaceuticals, Inc. | Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual |
US20100203556A1 (en) * | 2008-04-07 | 2010-08-12 | Arena Pharmaceuticals, Inc. | Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy |
US7781584B2 (en) | 2004-03-15 | 2010-08-24 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7790734B2 (en) | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7825242B2 (en) | 2004-07-16 | 2010-11-02 | Takeda Pharmaceutical Company Limted | Dipeptidyl peptidase inhibitors |
US20110009433A1 (en) * | 2008-03-10 | 2011-01-13 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic pyrrole compound |
WO2011005929A1 (en) | 2009-07-09 | 2011-01-13 | Arena Pharmaceuticals, Inc. | Piperidine derivative and its use for the treatment of diabets and obesity |
US7872124B2 (en) | 2004-12-21 | 2011-01-18 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20110092510A1 (en) * | 2008-06-03 | 2011-04-21 | Boehringer Ingelheim International Gmbh | Dpp-iv inhibitors for use in the treatment of nafld |
US7960384B2 (en) | 2006-03-28 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20110190322A1 (en) * | 2008-08-14 | 2011-08-04 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
US20110206766A1 (en) * | 2008-04-03 | 2011-08-25 | Boehringer Ingelheim International Gmbh | Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
WO2011127051A1 (en) | 2010-04-06 | 2011-10-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US8071583B2 (en) | 2006-08-08 | 2011-12-06 | Boehringer Ingelheim International Gmbh | Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus |
US8084605B2 (en) | 2006-11-29 | 2011-12-27 | Kelly Ron C | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
WO2012040279A1 (en) | 2010-09-22 | 2012-03-29 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012089127A1 (en) * | 2010-12-29 | 2012-07-05 | Shanghai Fochon Pharmaceutical Co Ltd | Certain dipeptidyl peptidase inhibitors |
US8222411B2 (en) | 2005-09-16 | 2012-07-17 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US8513264B2 (en) | 2008-09-10 | 2013-08-20 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
WO2014100065A1 (en) * | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
US8846695B2 (en) | 2009-01-07 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor |
US8853156B2 (en) | 2008-08-06 | 2014-10-07 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients inappropriate for metformin therapy |
US8865729B2 (en) | 2008-12-23 | 2014-10-21 | Boehringer Ingelheim International Gmbh | Salt forms of a xanthine compound |
US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
US8906901B2 (en) | 2005-09-14 | 2014-12-09 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
US9149478B2 (en) | 2010-06-24 | 2015-10-06 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
US9186392B2 (en) | 2010-05-05 | 2015-11-17 | Boehringer Ingelheim International Gmbh | Combination therapy |
WO2016042775A1 (en) * | 2014-09-18 | 2016-03-24 | Sunovion Pharmaceuticals Inc. | Tricyclic derivative |
US9457029B2 (en) | 2009-11-27 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
US9486526B2 (en) | 2008-08-06 | 2016-11-08 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients inappropriate for metformin therapy |
EP2994128A4 (en) * | 2013-05-10 | 2016-11-23 | Nimbus Apollo Inc | ACC-HEMMER AND USES THEREOF |
US9526730B2 (en) | 2012-05-14 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
US9713618B2 (en) | 2012-05-24 | 2017-07-25 | Boehringer Ingelheim International Gmbh | Method for modifying food intake and regulating food preference with a DPP-4 inhibitor |
US9988399B2 (en) | 2013-05-10 | 2018-06-05 | Gilead Apollo, Llc | Bicyclic compounds as ACC inhibitors and uses thereof |
US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
US10208063B2 (en) | 2013-05-10 | 2019-02-19 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
US10208044B2 (en) | 2013-05-10 | 2019-02-19 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
US10555929B2 (en) | 2015-03-09 | 2020-02-11 | Coherus Biosciences, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
US11767321B2 (en) | 2020-10-05 | 2023-09-26 | Enliven Inc. | 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases |
US11911388B2 (en) | 2008-10-16 | 2024-02-27 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY28103A1 (es) * | 2002-12-03 | 2004-06-30 | Boehringer Ingelheim Pharma | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos |
JPWO2004096806A1 (ja) * | 2003-04-30 | 2006-07-13 | 大日本住友製薬株式会社 | 縮合イミダゾール誘導体 |
JP4806628B2 (ja) | 2003-05-05 | 2011-11-02 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤 |
EP1690863A1 (en) * | 2003-11-26 | 2006-08-16 | Dainippon Sumitomo Pharma Co., Ltd. | Novel condensed imidazole derivative |
CN102199151A (zh) * | 2004-02-18 | 2011-09-28 | 贝林格尔.英格海姆国际有限公司 | 8-[3-氨基-哌啶-1-基]-黄嘌呤、制备及用途 |
DE102004012366A1 (de) * | 2004-03-13 | 2005-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Imidazopyridazindione, deren Herstellung und deren Verwendung als Arzneimittel |
WO2005100346A1 (en) * | 2004-04-08 | 2005-10-27 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
CA2561210A1 (en) * | 2004-04-10 | 2005-10-20 | Boehringer Ingelheim International Gmbh | Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments |
DE102004022970A1 (de) * | 2004-05-10 | 2005-12-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazolderivate, deren Herstellung und deren Verwendung als Intermediate zur Herstellung von Arzneimitteln und Pestiziden |
DE102004038269A1 (de) * | 2004-08-06 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
AR051596A1 (es) * | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
JPWO2006112331A1 (ja) * | 2005-04-13 | 2008-12-11 | 大日本住友製薬株式会社 | 新規縮合ピロール誘導体 |
GB0526291D0 (en) | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
JP2008289437A (ja) * | 2007-05-28 | 2008-12-04 | Sony Corp | レーザーを用いた酵素活性測定方法及び酵素活性測定装置 |
JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
CN102791704B (zh) | 2010-03-10 | 2015-11-25 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶(qc, ec 2.3.2.5)的杂环抑制剂 |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
CN103261200B (zh) * | 2010-09-13 | 2016-03-30 | 阿迪维纳斯疗法有限公司 | 作为a2b腺苷受体拮抗剂的前药的嘌呤化合物、它们的制备方法及医药用途 |
JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
US9051329B2 (en) | 2011-07-05 | 2015-06-09 | Merck Sharp & Dohme Corp. | Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors |
WO2013097052A1 (en) * | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
CN103709163B (zh) * | 2012-09-29 | 2016-12-21 | 齐鲁制药有限公司 | 黄嘌呤衍生物、其制备方法及用途 |
AR096758A1 (es) * | 2013-06-28 | 2016-02-03 | Abbvie Inc | Inhibidores cristalinos de bromodominios |
EP3313841A1 (en) * | 2015-06-25 | 2018-05-02 | Boehringer Ingelheim International GmbH | Process for the preparation of a xanthine-based compound |
DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
CN108299436B (zh) * | 2018-02-09 | 2020-01-17 | 上海慈瑞医药科技股份有限公司 | 黄嘌呤类化合物及其药物组合物和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020161001A1 (en) * | 2000-07-04 | 2002-10-31 | Kanstrup Anders Bendtz | Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
US20020198205A1 (en) * | 2001-02-24 | 2002-12-26 | Frank Himmelsbach | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040082570A1 (en) * | 2002-02-25 | 2004-04-29 | Eisai Co., Ltd. | Xanthine derivative and DPPIV inhibitor |
US20050020574A1 (en) * | 2002-12-03 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh Co. Kg | New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US100199A (en) * | 1870-02-22 | Improvement in ditcher and grader | ||
US219178A (en) * | 1879-09-02 | Improvement in steam-pressure regulators | ||
US122228A (en) * | 1871-12-26 | Improvement in head-blocks | ||
GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
GB9906714D0 (en) | 1999-03-23 | 1999-05-19 | Ferring Bv | Compositions for improving fertility |
WO2002100372A2 (en) * | 2001-06-11 | 2002-12-19 | Firmenich Sa | Stable transparent perfuming emulsion |
ATE388951T1 (de) | 2001-07-03 | 2008-03-15 | Novo Nordisk As | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes |
WO2003104229A1 (ja) * | 2002-06-06 | 2003-12-18 | エーザイ株式会社 | 新規縮合イミダゾール誘導体 |
US7569574B2 (en) * | 2002-08-22 | 2009-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
MXPA05003252A (es) * | 2002-09-26 | 2005-07-05 | Eisai Co Ltd | Farmaco de combinacion. |
MXPA05005983A (es) | 2002-12-04 | 2005-08-18 | Eisai Co Ltd | Compuestos de anillo fusionado 1,3-dihidroimidazol. |
JPWO2004096806A1 (ja) | 2003-04-30 | 2006-07-13 | 大日本住友製薬株式会社 | 縮合イミダゾール誘導体 |
US7169926B1 (en) * | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20070219178A1 (en) * | 2003-12-04 | 2007-09-20 | Eisai Co., Ltd. | Preventive or therapeutic agents for multiple sclerosis |
-
2003
- 2003-06-03 WO PCT/JP2003/007010 patent/WO2003104229A1/ja active Application Filing
- 2003-06-03 CA CA2485641A patent/CA2485641C/en not_active Expired - Fee Related
- 2003-06-03 RU RU2004139111/04A patent/RU2297418C9/ru not_active IP Right Cessation
- 2003-06-03 JP JP2004511299A patent/JP3675813B2/ja not_active Expired - Fee Related
- 2003-06-03 EP EP03733276A patent/EP1514552A4/en not_active Withdrawn
- 2003-06-03 PL PL03374007A patent/PL374007A1/xx not_active Application Discontinuation
- 2003-06-03 BR BR0311697-2A patent/BR0311697A/pt not_active IP Right Cessation
- 2003-06-03 NZ NZ536794A patent/NZ536794A/en not_active IP Right Cessation
- 2003-06-03 AU AU2003241960A patent/AU2003241960B2/en not_active Ceased
- 2003-06-03 MX MXPA04012226A patent/MXPA04012226A/es active IP Right Grant
- 2003-06-03 CN CNB2006101515284A patent/CN100469778C/zh not_active Expired - Fee Related
- 2003-06-03 KR KR1020047019831A patent/KR100985160B1/ko not_active IP Right Cessation
- 2003-06-03 TW TW092115068A patent/TWI273104B/zh not_active IP Right Cessation
- 2003-06-03 US US10/516,971 patent/US20060100199A1/en not_active Abandoned
- 2003-06-03 CN CNB038189682A patent/CN100348599C/zh not_active Expired - Fee Related
- 2003-06-06 US US10/457,002 patent/US20040116328A1/en not_active Abandoned
-
2004
- 2004-08-30 JP JP2004249414A patent/JP4420334B2/ja not_active Expired - Fee Related
- 2004-11-11 IL IL16517804A patent/IL165178A0/xx not_active IP Right Cessation
-
2005
- 2005-01-04 IS IS7625A patent/IS7625A/is unknown
- 2005-01-04 ZA ZA200500041A patent/ZA200500041B/xx unknown
- 2005-01-05 NO NO20050054A patent/NO20050054L/no not_active Application Discontinuation
- 2005-08-26 US US11/212,407 patent/US20060063787A1/en not_active Abandoned
- 2005-12-01 HK HK05110940A patent/HK1078869A1/xx not_active IP Right Cessation
- 2005-12-01 HK HK07107870.3A patent/HK1100219A1/xx not_active IP Right Cessation
-
2008
- 2008-08-28 US US12/199,982 patent/US7772226B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020161001A1 (en) * | 2000-07-04 | 2002-10-31 | Kanstrup Anders Bendtz | Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
US20020198205A1 (en) * | 2001-02-24 | 2002-12-26 | Frank Himmelsbach | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040082570A1 (en) * | 2002-02-25 | 2004-04-29 | Eisai Co., Ltd. | Xanthine derivative and DPPIV inhibitor |
US20050020574A1 (en) * | 2002-12-03 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh Co. Kg | New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions |
Cited By (235)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040034014A1 (en) * | 2000-07-04 | 2004-02-19 | Kanstrup Anders Bendtz | Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
US7235538B2 (en) * | 2000-07-04 | 2007-06-26 | Novo Nordisk A/S | Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
US20060247226A1 (en) * | 2001-02-24 | 2006-11-02 | Frank Himmelsbach | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20100204250A1 (en) * | 2001-02-24 | 2010-08-12 | Boehringer Ingelheim Pharma & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20100173916A1 (en) * | 2001-02-24 | 2010-07-08 | Boehringer Ingelheim International Gmbh | Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
US20110144083A1 (en) * | 2001-02-24 | 2011-06-16 | Boehringer Ingelheim International Gmbh | Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
US20110144095A1 (en) * | 2001-02-24 | 2011-06-16 | Boehringer Ingelheim Pharma & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040082570A1 (en) * | 2002-02-25 | 2004-04-29 | Eisai Co., Ltd. | Xanthine derivative and DPPIV inhibitor |
US20060100199A1 (en) * | 2002-06-06 | 2006-05-11 | Seiji Yoshikawa | Novel condensed imidazole derivatives |
US20090018331A1 (en) * | 2002-06-06 | 2009-01-15 | Eisai R&D Management Co., Ltd. | Condensed imidazole derivatives |
US7772226B2 (en) | 2002-06-06 | 2010-08-10 | Eisai R&D Management Co., Ltd. | Condensed imidazole derivatives |
US20060063787A1 (en) * | 2002-06-06 | 2006-03-23 | Eisai Co., Ltd. | Condensed imidazole derivatives |
US8178541B2 (en) | 2002-08-21 | 2012-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US8119648B2 (en) | 2002-08-21 | 2012-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US9108964B2 (en) | 2002-08-21 | 2015-08-18 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20080255159A1 (en) * | 2002-08-21 | 2008-10-16 | Boehringer Ingelheim Pharma Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20040097510A1 (en) * | 2002-08-21 | 2004-05-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US10023574B2 (en) | 2002-08-21 | 2018-07-17 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US8664232B2 (en) | 2002-08-21 | 2014-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US9321791B2 (en) | 2002-08-21 | 2016-04-26 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US10202383B2 (en) | 2002-08-21 | 2019-02-12 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US9556175B2 (en) | 2002-08-21 | 2017-01-31 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions |
US7838529B2 (en) | 2002-08-22 | 2010-11-23 | Boehringer Ingelheim International Gmbh | Xanthine derivates, their preparation and their use in pharmaceutical compositions |
US7495005B2 (en) | 2002-08-22 | 2009-02-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, their preparation and their use in pharmaceutical compositions |
US20040166125A1 (en) * | 2002-08-22 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, their preparation and their use in pharmaceutical compositions |
US20040122228A1 (en) * | 2002-08-22 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20090131432A1 (en) * | 2002-08-22 | 2009-05-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivates, their preparation and their use in pharmaceutical compositions |
US7569574B2 (en) * | 2002-08-22 | 2009-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20060094722A1 (en) * | 2002-09-26 | 2006-05-04 | Eisai Co., Ltd. | Combination drug |
US7482337B2 (en) | 2002-11-08 | 2009-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040138214A1 (en) * | 2002-11-08 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20100144703A1 (en) * | 2002-11-08 | 2010-06-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7696212B2 (en) | 2002-11-08 | 2010-04-13 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7560450B2 (en) | 2002-11-21 | 2009-07-14 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20040138215A1 (en) * | 2002-11-21 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7109192B2 (en) * | 2002-12-03 | 2006-09-19 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions |
US20050020574A1 (en) * | 2002-12-03 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh Co. Kg | New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions |
US7524847B2 (en) | 2002-12-04 | 2009-04-28 | Eisai R&D Management Co., Ltd. | Fused 1,3-dihydro-imidazole ring compounds |
US20060111362A1 (en) * | 2002-12-04 | 2006-05-25 | Eisai Co., Ltd. | 1,3-Dihydroimidazole ring compound |
US7687625B2 (en) | 2003-03-25 | 2010-03-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20040242566A1 (en) * | 2003-03-25 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
US20040242568A1 (en) * | 2003-03-25 | 2004-12-02 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
WO2004108730A1 (en) * | 2003-06-05 | 2004-12-16 | Fujisawa Pharmaceutical Co., Ltd. | 1h-imidazo`4,5-d!pyridazines as dpp-iv inhibitors for the treatment of niddm |
US8034941B2 (en) | 2003-06-18 | 2011-10-11 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7566707B2 (en) | 2003-06-18 | 2009-07-28 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
WO2004111051A1 (de) * | 2003-06-18 | 2004-12-23 | Boehringer Ingelheim International Gmbh | Imidazopyridazinon- und imidazopyridonderivate, deren herstellung und deren verwendung als arzneimittel |
US20090258856A1 (en) * | 2003-06-18 | 2009-10-15 | Boehringer Ingelheim International Gmbh | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20050070706A1 (en) * | 2003-08-13 | 2005-03-31 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7790736B2 (en) | 2003-08-13 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7723344B2 (en) | 2003-08-13 | 2010-05-25 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US20050070535A1 (en) * | 2003-08-13 | 2005-03-31 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
US7790734B2 (en) | 2003-09-08 | 2010-09-07 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7550455B2 (en) | 2003-11-27 | 2009-06-23 | Boehringer Ingelheim International Gmbh | 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
US20070219178A1 (en) * | 2003-12-04 | 2007-09-20 | Eisai Co., Ltd. | Preventive or therapeutic agents for multiple sclerosis |
WO2005061505A1 (en) * | 2003-12-16 | 2005-07-07 | Pfizer Products Inc. | Bicyclic imidazolyl pyrimidin-4-one cannabinoid receptor ligands and uses thereof |
US20050171093A1 (en) * | 2003-12-17 | 2005-08-04 | Boehringer Ingelheim International Gmbh | New piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutial compositions |
WO2005058901A1 (de) * | 2003-12-17 | 2005-06-30 | Boehringer Ingelheim International Gmbh | Neue 2-(piperazin-1-yl)- und 2-([1,4]diazepan-1-yl)- imidazo[4,5-d]pyridazin-4-one, deren herstellung und deren verwendung als arzneimittel zur bekämpfung von diabetes mellitus |
US7217711B2 (en) | 2003-12-17 | 2007-05-15 | Boehringer Ingelheim International Gmbh | Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions |
US20050143377A1 (en) * | 2003-12-23 | 2005-06-30 | Boehringer Ingelheim International Gmbh | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
US7183280B2 (en) | 2003-12-23 | 2007-02-27 | Boehringer Ingelheim International Gmbh | Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
US20050234108A1 (en) * | 2004-02-18 | 2005-10-20 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
US8697868B2 (en) | 2004-02-18 | 2014-04-15 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
US20090137801A1 (en) * | 2004-02-18 | 2009-05-28 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
US7645763B2 (en) | 2004-02-23 | 2010-01-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition |
US20050187227A1 (en) * | 2004-02-23 | 2005-08-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20050203095A1 (en) * | 2004-03-13 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
US7393847B2 (en) | 2004-03-13 | 2008-07-01 | Boehringer Ingleheim International Gmbh | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
US7432262B2 (en) | 2004-03-13 | 2008-10-07 | Boehringer Ingelheim International Gmbh | Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions |
US20070142383A1 (en) * | 2004-03-13 | 2007-06-21 | Matthias Eckhardt | Imidazopyridazinediones, Their Preparation And Their Use As Pharmaceutical Compositions |
US7807689B2 (en) | 2004-03-15 | 2010-10-05 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8329900B2 (en) | 2004-03-15 | 2012-12-11 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8173663B2 (en) | 2004-03-15 | 2012-05-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8188275B2 (en) | 2004-03-15 | 2012-05-29 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7906523B2 (en) | 2004-03-15 | 2011-03-15 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7781584B2 (en) | 2004-03-15 | 2010-08-24 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8288539B2 (en) | 2004-03-15 | 2012-10-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7476671B2 (en) | 2004-04-10 | 2009-01-13 | Boehringer Ingelheim International Gmbh | 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
US20070088038A1 (en) * | 2004-04-10 | 2007-04-19 | Matthias Eckhardt | 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
US20090088569A1 (en) * | 2004-04-10 | 2009-04-02 | Matthias Eckhardt | 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation, and their use as pharmaceutical compositions |
US7179809B2 (en) | 2004-04-10 | 2007-02-20 | Boehringer Ingelheim International Gmbh | 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
US20050261352A1 (en) * | 2004-05-10 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
US7439370B2 (en) | 2004-05-10 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
US7667035B2 (en) | 2004-05-10 | 2010-02-23 | Boehringer Ingelheim International Gmbh | Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US20080312243A1 (en) * | 2004-06-24 | 2008-12-18 | Matthias Eckhardt | Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
US20060004074A1 (en) * | 2004-06-24 | 2006-01-05 | Boehringer Ingelheim International Gmbh | New imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
US7470716B2 (en) | 2004-06-24 | 2008-12-30 | Boehringer Ingelheim International Gmbh | Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
US7906539B2 (en) | 2004-06-24 | 2011-03-15 | Boehringer Ingelheim International Gmbh | Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
US7825242B2 (en) | 2004-07-16 | 2010-11-02 | Takeda Pharmaceutical Company Limted | Dipeptidyl peptidase inhibitors |
US20060058323A1 (en) * | 2004-09-11 | 2006-03-16 | Boehringer Ingelheim International Gmbh | New 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7495003B2 (en) | 2004-09-11 | 2009-02-24 | Boehringer Ingelheim International Gmbh | 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20060079541A1 (en) * | 2004-09-14 | 2006-04-13 | Boehringer Ingelheim International Gmbh | 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7495002B2 (en) | 2004-09-14 | 2009-02-24 | Boehringer Ingelheim International Gmbh | 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US20060142310A1 (en) * | 2004-11-05 | 2006-06-29 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines |
US9751855B2 (en) | 2004-11-05 | 2017-09-05 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
US9499546B2 (en) | 2004-11-05 | 2016-11-22 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
US8541450B2 (en) | 2004-11-05 | 2013-09-24 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines |
US20090192314A1 (en) * | 2004-11-05 | 2009-07-30 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines |
US7820815B2 (en) | 2004-11-05 | 2010-10-26 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines |
US8883805B2 (en) | 2004-11-05 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
US20090192129A1 (en) * | 2004-12-12 | 2009-07-30 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic pyrrole derivatives |
US7872124B2 (en) | 2004-12-21 | 2011-01-18 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US20080318922A1 (en) * | 2004-12-24 | 2008-12-25 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic Pyrrole Derivatives |
US20090149483A1 (en) * | 2004-12-24 | 2009-06-11 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic pyrrole derivatives |
US7601728B2 (en) | 2004-12-24 | 2009-10-13 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic pyrrole derivatives |
US8198232B2 (en) | 2005-01-10 | 2012-06-12 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US20100286153A1 (en) * | 2005-01-10 | 2010-11-11 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
US20060154866A1 (en) * | 2005-01-10 | 2006-07-13 | Zhi-Liang Chu | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US20100298333A1 (en) * | 2005-01-10 | 2010-11-25 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
US8003597B2 (en) | 2005-01-10 | 2011-08-23 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US20100137293A1 (en) * | 2005-01-10 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
US20100286172A1 (en) * | 2005-01-10 | 2010-11-11 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
US8022034B2 (en) | 2005-01-10 | 2011-09-20 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US7803753B2 (en) | 2005-01-10 | 2010-09-28 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US20100285495A1 (en) * | 2005-01-10 | 2010-11-11 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
US7803754B2 (en) | 2005-01-10 | 2010-09-28 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
US20100285494A1 (en) * | 2005-01-10 | 2010-11-11 | Arena Pharmaceuticals, Inc. | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
US8030270B2 (en) | 2005-01-10 | 2011-10-04 | Arena Pharmaceuticals, Inc. | Methods for identifying GLP-1 secretagogues |
US20070027168A1 (en) * | 2005-07-30 | 2007-02-01 | Waldemar Pfrengle | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
US8637530B2 (en) | 2005-07-30 | 2014-01-28 | Boehringer Ingelheim International Gmbh | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
US8106060B2 (en) | 2005-07-30 | 2012-01-31 | Boehringer Ingelheim International Gmbh | 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
US20070098781A1 (en) * | 2005-08-11 | 2007-05-03 | Loeffler Bernd M | Modified release compositions for DPP-IV inhibitors |
US8906901B2 (en) | 2005-09-14 | 2014-12-09 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
US8222411B2 (en) | 2005-09-16 | 2012-07-17 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7960384B2 (en) | 2006-03-28 | 2011-06-14 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7816364B2 (en) | 2006-04-11 | 2010-10-19 | Arena Pharmaceuticals, Inc. | GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto |
US8026212B2 (en) | 2006-04-11 | 2011-09-27 | Arena Pharmaceuticals, Inc. | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues |
US8026074B2 (en) | 2006-04-11 | 2011-09-27 | Arena Pharmaceuticals, Inc. | Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual |
US20100203038A1 (en) * | 2006-04-11 | 2010-08-12 | Arena Pharmaceuticals, Inc. | Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual |
US8017574B2 (en) | 2006-04-11 | 2011-09-13 | Arena Pharmaceuticals, Inc. | Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues |
US20100203577A1 (en) * | 2006-04-11 | 2010-08-12 | Arena Pharmaceuticals, Inc. | Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual |
US8580526B2 (en) | 2006-04-11 | 2013-11-12 | Arena Pharmaceuticals, Inc. | Methods of using GPR119 receptor to identify compounds which stimulate glucose-dependent insulinotropic peptide secretion |
EP2253311A2 (en) | 2006-04-11 | 2010-11-24 | Arena Pharmaceuticals, Inc. | Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto |
US8101626B2 (en) | 2006-04-11 | 2012-01-24 | Arena Pharmaceuticals, Inc. | GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto |
US7833730B2 (en) | 2006-04-11 | 2010-11-16 | Arena Pharmaceuticals, Inc. | Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual |
US20100203037A1 (en) * | 2006-04-11 | 2010-08-12 | Arena Pharmaceuticals, Inc. | Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual |
US20100190750A1 (en) * | 2006-04-11 | 2010-07-29 | Arena Pharmaceuticals, Inc. | GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto |
US11084819B2 (en) | 2006-05-04 | 2021-08-10 | Boehringer Ingelheim International Gmbh | Polymorphs |
US9173859B2 (en) | 2006-05-04 | 2015-11-03 | Boehringer Ingelheim International Gmbh | Uses of DPP IV inhibitors |
US11291668B2 (en) | 2006-05-04 | 2022-04-05 | Boehringer Ingelheim International Gmbh | Uses of DPP IV inhibitors |
US9266888B2 (en) | 2006-05-04 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Polymorphs |
US20080107731A1 (en) * | 2006-05-04 | 2008-05-08 | Anja Kohlrausch | Dpp iv inhibitor formulations |
US9493462B2 (en) | 2006-05-04 | 2016-11-15 | Boehringer Ingelheim International Gmbh | Polymorphs |
US8232281B2 (en) | 2006-05-04 | 2012-07-31 | Boehringer Ingelheim International Gmbh | Uses of DPP-IV inhibitors |
US11033552B2 (en) | 2006-05-04 | 2021-06-15 | Boehringer Ingelheim International Gmbh | DPP IV inhibitor formulations |
US10080754B2 (en) | 2006-05-04 | 2018-09-25 | Boehringer Ingelheim International Gmbh | Uses of DPP IV inhibitors |
US8673927B2 (en) | 2006-05-04 | 2014-03-18 | Boehringer Ingelheim International Gmbh | Uses of DPP-IV inhibitors |
US20070281940A1 (en) * | 2006-05-04 | 2007-12-06 | Klaus Dugi | Uses of dpp-iv inhibitors |
US10301313B2 (en) | 2006-05-04 | 2019-05-28 | Boehringer Ingelheim International Gmbh | Polymorphs |
US20070259900A1 (en) * | 2006-05-04 | 2007-11-08 | Peter Sieger | Polymorphs |
US11919903B2 (en) | 2006-05-04 | 2024-03-05 | Boehringer Ingelheim International Gmbh | Polymorphs |
US9815837B2 (en) | 2006-05-04 | 2017-11-14 | Boehringer Ingelheim International Gmbh | Polymorphs |
US20110065731A1 (en) * | 2006-05-04 | 2011-03-17 | Boehringer Ingelheim International Gmbh | Uses of dpp-iv inhibitors |
US8071583B2 (en) | 2006-08-08 | 2011-12-06 | Boehringer Ingelheim International Gmbh | Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
US8084605B2 (en) | 2006-11-29 | 2011-12-27 | Kelly Ron C | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
AU2008290582B2 (en) * | 2007-08-17 | 2014-08-14 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
EP2190434B1 (en) | 2007-08-17 | 2019-04-17 | Boehringer Ingelheim International GmbH | Purin derivatives for use in the treatment of fap-related diseases |
US20110112069A1 (en) * | 2007-08-17 | 2011-05-12 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
WO2009024542A3 (en) * | 2007-08-17 | 2009-05-22 | Boehringer Ingelheim Int | Purin derivatives for use in the treatment of fab-related diseases |
WO2009024542A2 (en) * | 2007-08-17 | 2009-02-26 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
EP3542801A1 (en) * | 2007-08-17 | 2019-09-25 | Boehringer Ingelheim International GmbH | Purin derivatives for use in the treatment of fap-related diseases |
WO2009111501A1 (en) * | 2008-03-04 | 2009-09-11 | Smithkline Beecham Corporation | Derivatives of imidazo [4, 5-d] pyridazine and their use as anti-viral compounds |
US20110009433A1 (en) * | 2008-03-10 | 2011-01-13 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic pyrrole compound |
US10022379B2 (en) | 2008-04-03 | 2018-07-17 | Boehringer Ingelheim International Gmbh | DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
US9155705B2 (en) | 2008-04-03 | 2015-10-13 | Boehringer Ingelheim International Gmbh | DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
US10973827B2 (en) | 2008-04-03 | 2021-04-13 | Boehringer Ingelheim International Gmbh | DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
US20110206766A1 (en) * | 2008-04-03 | 2011-08-25 | Boehringer Ingelheim International Gmbh | Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
US9415016B2 (en) | 2008-04-03 | 2016-08-16 | Boehringer Ingelheim International Gmbh | DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
US8486646B2 (en) | 2008-04-07 | 2013-07-16 | Arena Pharmaceuticals, Inc. | Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues |
US8883714B2 (en) | 2008-04-07 | 2014-11-11 | Arena Pharmaceuticals, Inc. | Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues |
US20100203556A1 (en) * | 2008-04-07 | 2010-08-12 | Arena Pharmaceuticals, Inc. | Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy |
US7838254B2 (en) | 2008-04-07 | 2010-11-23 | Arena Pharmaceuticals, Inc. | Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
US20100210666A1 (en) * | 2008-04-07 | 2010-08-19 | Arena Pharmaceuticals, Inc. | Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy |
US20110092510A1 (en) * | 2008-06-03 | 2011-04-21 | Boehringer Ingelheim International Gmbh | Dpp-iv inhibitors for use in the treatment of nafld |
US8853156B2 (en) | 2008-08-06 | 2014-10-07 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients inappropriate for metformin therapy |
US10034877B2 (en) | 2008-08-06 | 2018-07-31 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients inappropriate for metformin therapy |
US9486526B2 (en) | 2008-08-06 | 2016-11-08 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients inappropriate for metformin therapy |
US20110190322A1 (en) * | 2008-08-14 | 2011-08-04 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
US8513264B2 (en) | 2008-09-10 | 2013-08-20 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
US11911388B2 (en) | 2008-10-16 | 2024-02-27 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
US8865729B2 (en) | 2008-12-23 | 2014-10-21 | Boehringer Ingelheim International Gmbh | Salt forms of a xanthine compound |
US9212183B2 (en) | 2008-12-23 | 2015-12-15 | Boehringer Ingelheim International Gmbh | Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine |
US8846695B2 (en) | 2009-01-07 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor |
WO2011005929A1 (en) | 2009-07-09 | 2011-01-13 | Arena Pharmaceuticals, Inc. | Piperidine derivative and its use for the treatment of diabets and obesity |
US9457029B2 (en) | 2009-11-27 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
US10092571B2 (en) | 2009-11-27 | 2018-10-09 | Boehringer Ingelheim International Gmbh | Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
WO2011127051A1 (en) | 2010-04-06 | 2011-10-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US9603851B2 (en) | 2010-05-05 | 2017-03-28 | Boehringer Ingelheim International Gmbh | Combination therapy |
US9186392B2 (en) | 2010-05-05 | 2015-11-17 | Boehringer Ingelheim International Gmbh | Combination therapy |
US10004747B2 (en) | 2010-05-05 | 2018-06-26 | Boehringer Ingelheim International Gmbh | Combination therapy |
US9149478B2 (en) | 2010-06-24 | 2015-10-06 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
WO2012040279A1 (en) | 2010-09-22 | 2012-03-29 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
EP3323818A1 (en) | 2010-09-22 | 2018-05-23 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
US11911387B2 (en) | 2010-11-15 | 2024-02-27 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
WO2012089127A1 (en) * | 2010-12-29 | 2012-07-05 | Shanghai Fochon Pharmaceutical Co Ltd | Certain dipeptidyl peptidase inhibitors |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US8962636B2 (en) | 2011-07-15 | 2015-02-24 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
US9199998B2 (en) | 2011-07-15 | 2015-12-01 | Boehringer Ingelheim Internatioal Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
US10195203B2 (en) | 2012-05-14 | 2019-02-05 | Boehringr Ingelheim International GmbH | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
US9526730B2 (en) | 2012-05-14 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
US9713618B2 (en) | 2012-05-24 | 2017-07-25 | Boehringer Ingelheim International Gmbh | Method for modifying food intake and regulating food preference with a DPP-4 inhibitor |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
AU2013361694B2 (en) * | 2012-12-20 | 2017-10-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as HDM2 inhibitors |
WO2014100065A1 (en) * | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
US8846657B2 (en) | 2012-12-20 | 2014-09-30 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as HDM2 inhibitors |
US10208063B2 (en) | 2013-05-10 | 2019-02-19 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
US9765089B2 (en) | 2013-05-10 | 2017-09-19 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
EP2994128A4 (en) * | 2013-05-10 | 2016-11-23 | Nimbus Apollo Inc | ACC-HEMMER AND USES THEREOF |
US10208044B2 (en) | 2013-05-10 | 2019-02-19 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
US9988399B2 (en) | 2013-05-10 | 2018-06-05 | Gilead Apollo, Llc | Bicyclic compounds as ACC inhibitors and uses thereof |
AU2014262546B2 (en) * | 2013-05-10 | 2018-11-08 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
WO2016042775A1 (en) * | 2014-09-18 | 2016-03-24 | Sunovion Pharmaceuticals Inc. | Tricyclic derivative |
US11400072B2 (en) | 2015-03-09 | 2022-08-02 | Coherus Biosciences, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US10772865B2 (en) | 2015-03-09 | 2020-09-15 | Coherus Biosciences, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US10555929B2 (en) | 2015-03-09 | 2020-02-11 | Coherus Biosciences, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
US11767321B2 (en) | 2020-10-05 | 2023-09-26 | Enliven Inc. | 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases |
US11807638B2 (en) | 2020-10-05 | 2023-11-07 | Enliven Inc. | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7772226B2 (en) | Condensed imidazole derivatives | |
KR100867485B1 (ko) | 병용 의약 | |
US20070219178A1 (en) | Preventive or therapeutic agents for multiple sclerosis | |
US6756373B1 (en) | Pharmaceutically active compounds | |
US8148387B2 (en) | AKT and P70 S6 kinase inhibitors | |
US7268128B2 (en) | 1,3,5-trisubstituted-5-phenyl and 5-pyridyl pyrazolopyrimidinone derivatives having PDE7 inhibiting action | |
WO2011013729A1 (ja) | Ttk阻害作用を有する縮合イミダゾール誘導体 | |
TW201011026A (en) | Therapeutic agents 414 | |
EP1780212A1 (en) | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EISAI CO., LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YOSHIKAWA, SEIJI;EMORI, EITA;MATSUURA, FUMIYOSHI;AND OTHERS;REEL/FRAME:014099/0045 Effective date: 20031027 |
|
AS | Assignment |
Owner name: EISAI CO., LTD., JAPAN Free format text: CORRECTION OF ASSIGNEE ADDRESS ON NOTICE OF RECORDATION FOR ASSIGNMENT RECORDED 10/31/03 AT REEL/FRAME 014099/0045;ASSIGNORS:YOSHIKAWA, SEIJI;EMORI, EITA;MATSUURA, FUMIYOSHI;AND OTHERS;REEL/FRAME:014498/0976 Effective date: 20031027 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |